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ABSTRACT
Both infectious and noninfectious disease agents in wildlife impact human health and 
accurate research, monitoring, and diagnostic methods are necessary. The objectives of the 
research reported here were to develop and implement novel methods for bacterial and 
toxicological disease agent surveillance in wildlife. This dissertation begins with a review of 
tularemia, an important zoonotic disease to the state of Alaska and the Northern 
hemisphere. In chapter two, I show the development and implementation of broad-based 
PCR and quantitative PCR [qPCR) surveillance methods for bacterial DNA in tissue samples; 
1298 tissue samples were assayed, numerous potential bacterial pathogens were identified 
and qPCR detection limits were quantified for various tissue matrices. Chapter three 
describes an investigation into microbial infection as a source of embryo mortality in 
greater white-fronted geese [Anser albifrons) in Arctic Alaska. This chapter builds upon our 
previously developed PCR surveillance techniques by which I demonstrated that bacterial 
infection is responsible for some greater white-fronted goose embryo mortality in Arctic 
Alaska. Chapter four describes the development and validation of a cellulose filter paper 
method for quantifying total mercury in whole blood. I determined that filter paper 
technology is useful for monitoring total mercury in whole blood, with excellent recoveries 
[82 - 95%  of expected values) and R2 values [0.95 - 0.97) when regressed against the 
concentration of total mercury in whole blood, the technique generally considered as the 
"gold standard" for mercury detection. These methods will aid in the accurate detection of 
disease agents in wildlife as demonstrated by our white-fronted goose work.
v
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General Introduction
Human, animal, and ecosystem health are mutually interdependent and this 
relationship has been historically postulated on the basis of empirical observation. 
However, scientists, biologists, and human and animal health professionals often operate 
independently and may overlook interrelationships. To promote a collaborative effort 
between all those involved in medical care at large, in the early 2000's the One Health (OH) 
Initiative started taking shape. The mission statement of OH indicates that "One Health 
seeks to promote, improve, and defend the health and well-being of all species by 
enhancing cooperation and collaboration between physicians, veterinarians, other 
scientific health and environmental professionals and by promoting strengths in leadership 
and management to achieve these goals" (www.onehealthinitiative.com). The OH initiative 
is a collaborative effort between governmental agencies (e.g. the Centers for Disease 
Control and Prevention), nongovernmental organizations (e.g. the American Veterinary 
Medical Association), universities, and industry to promote the OH concept. Not only is the 
physical health of humans and animals related via disease, but humans' emotional well­
being can be impacted by their perception of animal health, in that people feel good 
knowing that animal populations are healthy [1].
Alaska is a unique place to apply the OH concept. Many Alaska residents rely on wild 
animal resources for subsistence. Additionally, Alaska has a large tourism industry, much of 
which involves wildlife viewing. Alaska is also home to several zoonotic and wildlife 
diseases of importance [2]. Finally, climate change is resulting in warmer temperatures, 
which will theoretically cause drastic changes in host-pathogen interactions [3]. Therefore 
it is important that we monitor and study diseases in wild animal populations in Alaska.
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In order to properly monitor animal diseases it is important understand these 
diseases and to have useful diagnostic tools. This dissertation begins by describing an 
example of a bacterial disease of importance to Alaska and the Northern hemisphere, 
tularemia. Then it describes broad-based polymerase chain reaction and sequencing 
methods for detection of bacterial DNA in wild animal tissues as a means of detecting and 
identifying disease agents. Next we applied these and other techniques to investigate avian 
embryo mortality in a field situation using those broad-based PCR and sequencing and 
other techniques. Finally, we move into the realm of noninfectious disease, and validate the 
use of a cellulose filter paper based sampling technique for use for mercury quantification 
in whole blood.
Tularemia is an example of a zoonotic bacterial disease that is classified as a 
category A select pathogen1 by the CDC. Tularemia is caused by the Gram-negative 
bacterium Francisella tularensis [4]. F. tularensis is an obligate pathogen; rodents and 
lagomorphs are thought to be reservoir hosts [5], and is transmitted to humans either 
directly or via arthropod vectors. Depending on the subspecies of tularemia contracted and 
the route of entry, the disease can be up to 50% fatal in humans [6]. The pathological 
manifestations caused by F. tularensis may vary as a function of the route of entry and can 
present itself as infection of skin and lymph nodes (ulceroglandular), or lungs (pneumonic, 
the most serious form) [6]. Other, rarer forms of the disease include oculoglandular
1 Category A select pathogens are those organisms/biological agents that pose the highest 
risk to national security and public health because they can be easily disseminated or 
transmitted from person to person, result in high mortality rates and have the potential for 
major public health impact, might cause public panic and social disruption, and require 
special action for public health preparedness (www.cdc.gov).
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(infection of the eye), oropharyngeal (infection of the upper gastro-intestinal tract), and 
typhoidal (systemic infection without an ulcer).
The bacterium currently known as F. tularensis was first isolated from a ground 
squirrel in Tulare County, California, USA in 1911 [6] and since then F. tularensis has been 
isolated from more than 250 host species [7]. The severity of disease depends not only on 
route of exposure, but also on bacterial type [8]. F. tularensis is found throughout the 
Northern hemisphere and there are four recognized subspecies. The most virulent 
subspecies is F. tularensis subsp. tularensis, also known as "type A", and is found 
throughout North America. "Type B" tularemia is caused by F. tularensis subsp. holarctica, 
causes less severe disease, and is found throughout the Northern hemisphere. F. tularensis 
subsp. mediasiatica also generally causes mild disease, and is found in central Asia. The 
final subspecies, F. tularensis subsp. novicida, is considered avirulent in humans, and its 
classification is disputed. Chapter one of this thesis reviews the history of tularemia in 
wildlife and humans in the state of Alaska and describes the genetic characterization of 
recent Alaskan F. tularensis isolates.
Tularemia is an infectious disease of concern in Alaska and the Northern 
Hemisphere, and diagnosing this bacterial disease and others is important to both animal 
and human health. Numerous methods exist for surveillance of bacterial disease. However, 
none of them are truly unbiased or broad-based and able to detect a wide variety of 
bacterial species. Current methods for detecting past or current exposure to bacteria 
(including pathogens) include polymerase chain reaction (PCR), culture, and serology.
Bacteriologic culture is the gold standard for diagnosing most bacterial infections [9, 
10]. Culturing confirms that live organisms are present, and determines biochemical and
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phenotypic characteristics of the organism of interest. Despite being the gold standard, 
culturing is subject to limitations, namely that the bacteria in the sample must be alive and 
culturable to get a true positive result. Additional limitations include biosafety concerns, 
and that some bacteria are fastidious and require special growth media [2, 11].
Polymerase chain reaction (PCR) is a highly sensitive diagnostic tool that can 
determine the presence of bacterial DNA. The 16S ribosomal RNA gene is common to all 
bacteria. It encodes the 16S ribosomal RNA subunit, a structure essential for bacterial cell 
function. The gene contains regions that are highly conserved, allowing for the design of 
universal primers [12, 13]. It also has variable and hypervariable regions that allow for 
differentiation between bacterial taxa. This combination has made PCR, sequencing, and 
analysis of the 16S rRNA gene a very useful tool in bacterial phylogenetic analysis and is 
used extensively by microbiologists [14, 15]. Detection and sequencing of the 16S rRNA 
gene is beginning to be used by diagnosticians as well [16, 17, 18]. Chapter two of this 
thesis describes our development of both PCR and quantitative real-time PCR (qPCR) 
surveillance for bacterial DNA in animal tissue samples. We then used the technique to 
screen more than 1200 wildlife tissue samples for the presence of bacterial DNA and, in 
some cases to identify the bacteria present.
In chapter three, the broad-based PCR surveillance method developed above is used 
to investigate embryo mortality in greater white-fronted geese (Anser albifrons) on the 
North Slope of Alaska. Mechanisms of avian embryo mortality are poorly understood and 
recently microbial infection is being recognized as a cause [19, 20, 21]. Investigations into 
microbial sources of embryo mortality so far have focused on cavity-nesting tropical 
species and open-cup temperate nesting species, and none have focused on Arctic nesting
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species. Bacterial egg pathogens are known to be horizontally and vertically transmitted 
[22, 23], and incubation has been shown to inhibit bacterial penetration of eggs in tropical 
environments [20], but there is evidence that these mechanisms act differently in 
temperate environments [24, 25]. We are unaware of any studies of avian embryo 
mortality in the Arctic.
During the summers of 2011 and 2012 approximately 10% of greater white-fronted 
goose eggs monitored in Northern Alaska contained at least one nonviable egg. This, 
coupled with the abundance of white-fronted geese in the area afforded us the opportunity 
to investigate embryo mortality in an Arctic nesting waterfowl species. The main objective 
of this study was to assess microbial infection as a source of avian embryo mortality in 
white-fronted geese on the Arctic Coastal Plain of Alaska. More specifically, we aimed to 
identify bacteria in the contents of nonviable eggs, compare bacteria present within the 
cloacae of nesting females, nest materials, and on eggshells to the contents of nonviable 
eggs, and to perform an infection study in a laboratory setting to asses pathogenicity and 
establish causality.
In addition to infectious disease, toxicologic diseases are a concern to animals and 
humans alike, representing an area of interest that is shared between human, veterinary 
and environmental health. Mercury is a nonessential element and a heavy metal of concern 
around the world, particularly in human populations that subsist on seafood and marine 
mammals [26, 27]. Mercury (Hg) is released into the atmosphere via natural and 
anthropogenic activities. Following entry to the atmosphere, microbial activity in ocean 
and lake sediments can transform organic Hg into the more toxic monomethylmercury 
(MeHg+) [28, 29]. MeHg+ is readily absorbed by lower trophic level biota and biomagnifies
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up the food chain [30]. MeHg+ reaches particularly high levels in some fish species and in 
piscivorous marine mammals [26, 27].
Clinical signs of Hg toxicity depend on dose and chronicity. Signs of acute toxicity 
(which is relatively rare and normally results from occupational exposure) include 
proprioceptive deficits, abnormal postures, blindness, anorexia, coma, and death [31]. More 
commonly seen, and of concern in wildlife, is chronic MeHg+ exposure. There is evidence to 
show that chronic exposure to MeHg+ can result in poor reproductive success, and impact 
behavior, cognition, and health [32, 33, 34]. Monitoring MeHg+ exposure in wildlife is 
therefore important. Blood is the route of exposure for target organs (the central nervous 
system), and is therefore used in monitoring recent Hg exposure.
Collection of whole blood from wildlife in field situations can be problematic, 
particularly in remote locations with limited or no preservation or processing capabilities. 
Chapter four of this thesis describes the validation of a filter paper based sampling regime 
for the quantification of Hg in whole blood in two marine mammal species. This technique 
can be easily used in the field by scientists, hunters, fishermen, veterinarians or other 
trained personnel and will facilitate clinical and research monitoring efforts.
Taken together, these chapters highlight the importance of monitoring both 
infectious and noninfectious disease agents, and they describe new methods for 
surveillance. In addition, the development and implementation of two methods for 
assessing disease in wildlife will expand the toolbox of wildlife disease professionals. 
Chapter one describes a zoonotic disease of importance (tularemia) throughout Alaska and 
the Northern hemisphere. Chapter two describes development and implementation of a 
broad-based PCR surveillance and sequencing method for identifying bacterial DNA in
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animal blood and tissue samples. Chapter three utilizes this broad-based PCR technique 
(and others) in an investigation of avian embryo mortality in the Arctic. Finally, chapter 
four describes and validates a novel method for monitoring mercury exposure in marine 
mammal whole blood.
In conclusion, simple and accurate methods to identify infectious and toxic agents in 
disease assessment may lead to a more comprehensive monitoring of wildlife health, which 
in turn might lead to interventions designed to improve wildlife health. According to the 
One Health paradigm, an improvement in wildlife health may also aid in improving human 
and environmental health.
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CHAPTER 1:
Tularem ia in Alaska: 19 3 8 -2 0 1 0 1 
Abstract
Tularemia is a serious, potentially life threatening zoonotic disease. The causative agent, 
Francisella tularensis, is ubiquitous in the Northern hemisphere, including Alaska, where it 
was first isolated from a rabbit tick (Haemophysalis leporis-palustris) in 1938. Since then, F. 
tularensis has been isolated from wildlife and humans throughout the state. Serologic 
surveys have found measurable antibodies with prevalence ranging from <1% to 50% and 
4% to 18% for selected populations of wildlife species and humans, respectively. We 
reviewed and summarized known literature on tularemia surveillance in Alaska and 
summarized the epidemiological information on human cases reported to public health 
officials. Additionally, available F. tularensis isolates from Alaska were analyzed using 
canonical SNPs and a multi-locus variable-number tandem repeats (VNTR) analysis 
(MLVA) system. The results show that both F. t. tularensis and F. t. holarctica are present in 
Alaska and that subtype A.I, the most virulent type, is responsible for most recently 
reported human clinical cases in the state.
1 Hansen CM, Vogler AJ, Keim P, Wagner DM, Hueffer K. Tularem ia in Alaska: 1 9 3 8 ­
2010. Acta Vet Scand 2011, 53:61.
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1.1 Introduction
Tularemia is a serious and potentially life threatening zoonotic disease caused by 
the Gram-negative bacterium Francisella tularensis. Due to its high virulence and zoonotic 
potential, F. tularensis is listed as a category A select bioterrorism agent. F. tularensis has 
been weaponized in the past by the United States, Japan, the former USSR, and potentially 
other countries [1]. The organism was first isolated from a ground squirrel in 1911 in 
Tulare County, CA. It was named Bacterium tularense, was later reclassified as Pasteurella 
tularense, and finally, in 1966, was named Francisella tularensis after Edward Francis. 
Descriptions of a plague-like disease now considered to be tularemia predate this first 
isolation, going as far back as 1818 in Japan [2]. The first laboratory-confirmed human case 
was reported in 1914 [3]. Since then F. tularensis has been isolated from more than 250 
host species [4].
F. tularensis is ubiquitous in the Northern hemisphere and currently there are four 
recognized subspecies. F. tularensis subsp. tularensis (type A) is the most virulent of 
subspecies and is found throughout North America. F. tularensis subsp. holarctica (type B) 
is less virulent and is found throughout the Northern hemisphere. The distinction between 
type A and B tularemia was first made in the middle of the 20th century [5]. Type A is 
divided into types A.I and A.II, and A.I is still further divided into types A.Ia and A.Ib. In a 
review of isolates collected in the US over 40 years, the highest human mortality rate was 
associated with type A.Ib (12/49 or 24%), followed by type B (8/108 or 7%), type A.Ia 
(2/55 or 4%), and finally, type A.II (0/53 or 0%)[6]. The third subspecies, F. tularensis 
subsp. mediasiatica is virulent and has been isolated in central Asia. Finally, many consider 
F. tularensis subsp. novicida to be a fourth subspecies of F. tularensis based on genetics and
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biochemical requirements [7], though this classification is still disputed [8,9]. F. tularensis 
subsp novicida is generally avirulent in humans and is distributed globally [2,10].
The disease caused by F. tularensis depends on the route of entry. Ulceroglandular 
tularemia, the most common form of disease, results from exposure through the skin 
(either preexisting wound or arthropod bite). This form results in an ulcer at the site of 
infection followed by lymphadenopathy. Pneumonic tularemia, the most serious form of 
disease, results from inhalation of aerosolized bacteria. Other forms of the disease include 
oculoglandular (exposure via the eye), oropharyngeal (ingestion), and typhoidal tularemia 
(systemic infection without a primary ulcer).
Here we review the history of tularemia in both wildlife and humans in the state of 
Alaska. We also report on the genetic characterization of recent Alaskan F. tularensis 
human and animal isolates using canonical SNPs (canSNPs) and multi-locus variable 
tandem repeat (VNTR) analysis (MLVA).
1.2 Tularem ia in Wildlife in Alaska
In Alaska, F. tularensis was first isolated from a rabbit tick (Haemophysalis leporis- 
palustris) removed from a varying hare (Lepus americanus) near Fairbanks in 1938 [11]. 
The isolated strain was virulent in both guinea pigs and rabbits, resulting in enlarged 
spleens and areas of focal necrosis in both the spleens and livers. The high virulence in 
both species suggests that the isolate may have been type A. Later, an additional two 
virulent and likely type A isolates were obtained when suspensions of ground ticks 
removed from two healthy hares were inoculated into guinea pigs [12,13]. Isolates 
collected from subsequent animals indicated the presence of a less virulent type, likely type
B. The first of these was an isolate obtained from ticks collected from willow ptarmigan
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(Lagopus lagopus) in the Fairbanks area in 1959 [14]. Voles sampled during the summer of 
1963 on the Alaska Peninsula revealed a large number with splenomegaly and resulted in 
the isolation of another less virulent isolate [15]. During the summer of 1971 in the 
Fairbanks area, 10 of 24 hares had enlarged spleens from which F. tularensis was isolated 
[16]. This isolate was compared to the vole isolate from 1963 [15] and shown to be 
significantly more virulent in challenge studies, further supporting the coexistence of type 
A and B strains in Alaska [16] (Table 1.1).
Though few isolates have been obtained, serological surveys for tularemia 
conducted between 1964 and 2000 have indicated the presence of F. tularensis among a 
wide variety of wildlife species and across a wide geographic area in Alaska. Seropositive 
animals (titer >1:20) in these surveys included various rodents and hares, birds and large 
predators (Table 1.2). Of those titers reported, the range was 1:20 - 1:320 [14, 17, 18, 19, 
20]. These serology results are consistent with the wide number of species in which F. 
tularensis has been found [4], but revealed few clues as to the important reservoir(s) for F. 
tularensis in Alaska. Of note, however, were two studies by Zarnke et al. [19,20], which 
found that positive tularemia serology peaks in predators followed peaks in snowshoe hare 
populations, suggesting the possibility of a hare reservoir. In addition, F. tularensis DNA 
was found in 30% of >2500 mosquitoes in Alaska, suggesting the possibility of an 
arthropod reservoir as well [21].
1.3 History of Human Tularem ia in Alaska
The first possible case of human tularemia in Alaska was reported in 1938 in a 62- 
year-old man from Wiseman, north of the Arctic Circle. The patient exhibited symptoms of 
ulceroglandular tularemia and was hospitalized for 2 months, though there was no
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laboratory confirmation of tularemia [13]. In 1946, a 31-year-old male from Northway 
(interior Alaska) with a history of skinning muskrats became the first laboratory-confirmed 
case by serology (titer 1:1280). His symptoms were headache, orbital pain, general aches 
and fever followed by development of swollen lymph nodes. The patient also reported that 
an ulcerated lesion had been present on his left middle finger for about one week.
However, no isolate was cultured [22]. The first culture positive human infection occurred 
in 1974 in a 42-year-old laboratory worker with pneumonia whose pleural fluid yielded an 
isolate of F. tularensis [23].
Following the diagnosis of these initial cases of tularemia, surveillance projects were 
conducted throughout the state. The first of these occurred between 1954 and 1957 and 
involved 816 skin tests of inhabitants of Alaskan villages, of which 64 (8%) were positive, 
with 50 -  59 year olds having the highest incidence by age group [24]. The highest 
incidence was found in central Alaska, between Minto and Kaltag and as far north as 
Hughes, corresponding with the rich trapping areas in central Alaska. Following this initial 
surveillance, two additional surveys of Alaska Natives were completed. First, in the 1960s, 
serological surveys of 793 Aleut, Indian and Eskimo men showed an overall detection rate 
of 18% (139 of 793), with titers ranging from 1:20 to 1:640. A second survey involved skin 
tests on a subset of 115 (15%) of these Alaska Natives. Fifty-one (44%) of the 115 had 
positive skin tests, 43 (84%) of which also had detectable titers in the first survey, 
indicating a high correlation between skin test and titer results. Following these results, 
questionnaires were completed to determine if clinical disease resembling tularemia had 
been present. No difference in either total illness or tularemia-like illness was found
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between seropositive and seronegative groups, suggesting that the tularemia present in 
Alaska Natives may be of a less virulent type [25].
A final survey of Alaska Natives was completed in 1974. In this study, there were 
4% (29 of 810) and 7% (28 of 402) positive titer rates (>1:80, range 1:80-1:1280) in 
southwestern and east central Alaska, respectively. In addition, two seroconversions in 
children were documented (both >4-fold increase in titer), with one child reporting a rash 
at around the time of the rise in titer and the other exhibiting no signs of disease. Similar to 
the previous surveys, no cases of tularemia-like illness were described in the villages 
studied, again suggesting that the tularemia present in these villagers was due to a less 
virulent type, that the route of infection favors asymptomatic disease or that Alaska Natives 
have developed resistance [23].
In 1993, two human cases related to housecats occurred in Fairbanks. One patient 
was a 44-year-old man who had been bitten on the thumb by his cat three and a half weeks 
prior to admission. Prior to the man’s illness, his cat had been seen by a veterinarian and 
treated with antibiotics for an unknown febrile illness. The second patient was a 42-year- 
old veterinarian who presented with similar symptoms. The veterinarian had treated 
several cats with tularemia during the two-month period prior to his illness. Both human 
cases resolved with appropriate antibiotics [26].
Following the above housecat-associated cases, a serological survey of veterinarians 
was done in the Fairbanks area; two of 14 veterinarians (14%) had positive titers (>1:80) 
for tularemia. Questionnaires sent to Fairbanks physicians and veterinarians indicated that 
54% (15/28) and 92%  (11/12), respectively, were aware that tularemia was prevalent in 
local wildlife. In addition, nine veterinarians had treated local domestic cats or dogs for
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suspected tularemia, indicating that household pets can pose a significant source for 
human infection [26].
1.4 Epidemiology of Reported Human Cases in Alaska 1946-2010
Between 1946 and 2010, a total of 38 cases of tularemia were known to public 
health authorities in Alaska, with 9 cases in the Fairbanks-Steese area between 1946 and 
1953 [27] and an additional 29 cases from throughout the entire state between 1972 and 
2009. Of the 38 reported cases, 23 were laboratory confirmed, with detailed laboratory 
data available for 19 of those 23. Of these 19, 10 had four-fold changes in paired titers, 7 
had positive cultures for F. tularensis, 1 had a positive lymph node stain and 1 had a single 
high titer along with clinical and epidemiological evidence. Seventy-three percent (22 of 
30) of the patients were male with a median age of 39 years (range of 15-59 years). 
Seventy-one percent (27 of 38) were white and 16% (6 of 38) were of unknown race. Most 
(69%, 20 of 29) had illness onsets between June and August. Geographically, 68%  (26 of 
38) were exposed in central eastern Alaska, 21% (8 of 38) in the greater Anchorage area, 
5% (2 of 38) in northwestern Alaska, 3% (1 of 38) in Southeastern Alaska and 3% (1 of 38) 
were exposed out-of-state. Ulceroglandular tularemia was most common (70%, 19 of 27), 
followed by typhoidal (11%, 3 of 27) and pneumonic (7%, 2 of 27) tularemia. None of the 
cases were fatal. Of those case-patients with detailed exposure histories, 79% (19 of 24) 
had direct contact with animals and 84% (16 of 19) of those had contact with a known 
wildlife reservoir (Figure 1.1). The remaining 16% (3 of 19) had had contact with domestic 
animals (one cat bite and two dogs known to have killed hares).
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1.5 Molecular Subtyping of Recent F. tularensis  Isolates
We subtyped DNAs from eight recent (2003-2009) F. tularensis isolates (6 hare and 
2 human) obtained by the public health laboratory of Alaska from interior Alaska and an 
additional four Alaskan DNAs (3 human and 1 rodent) available in Northern Arizona 
University’s F. tularensis DNA collection to determine if the presumed coexistence of types 
A and B in Alaska could be confirmed. We first subtyped the isolate DNAs using a set of 
canSNPs described by Vogler et al. [28] to identify the major F. tularensis subclades found 
in Alaska. We then subtyped the isolate DNAs using the MLVA system described by Vogler 
et. al. [29] in order to identify additional variation among the isolates.
The canSNP analysis identified 10 isolates as type A.I (6 hares, 1 rodent, 3 human), 
one as type A.II (human), and one as type B (human) (Figure 1.2). The canSNP assays 
further placed the type A.I isolates into subclade A.I.Br.001/002, the type A.II isolate into 
subclade A.II.Br.006/007 and the type B isolate into subclade B.Br.OR96-0246. This built 
upon a previous global analysis of F. tularensis, which had identified a single subclade 
A.I.Br.001/002 isolate (also included in this study) in Alaska [28]. This genetic analysis 
confirmed the previous virulence studies that had suggested the coexistence of types A and 
B in Alaska. Indeed, this analysis revealed an even greater level of genetic diversity than 
previously suspected, in that members of three major genetic groups were found to be 
present. The fact that most of these isolates were type A.I is likely related to the greater 
virulence of this genetic group [6] and thus the greater likelihood of severe disease and 
resultant opportunities for obtaining isolates through the public health system. However it 
is also possible that different strains are distributed differently throughout the 
environment, or that the reservoirs are distributed differently. It is probable that types B
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and A.II are present in much higher proportions in the wild than is indicated by this 
analysis. By relying on clinical isolates for genetic analysis we are limited to strains that 
are more likely to cause disease. Intensive sampling efforts would be needed to obtain 
more isolates from wildlife or people in the state.
The MLVA analysis revealed additional genetic diversity among the Alaskan isolates. 
Specifically, a neighbor-joining analysis based on MLVA data for the Alaskan isolates and an 
additional 34 A.I.Br.001/002 isolates revealed that the Alaskan subclade A.I.Br.001/002 
isolates did not form a monophyletic group. Rather, they were scattered amongst subclade 
A.I.Br.001/002 isolates from diverse North American geographic locations (Figure 1.2), 
indicating a relatively high level of genetic diversity within this subclade in Alaska. This 
relatively high level of genetic diversity suggests either multiple introductions of F. 
tularensis to Alaska, a long history of F. tularensis in Alaska with ample time for 
diversification and possible transfers to other geographic locations, or a combination of the 
two. However, it is important to note that such high levels of genetic diversity within a 
single geographic location are not unique to Alaska, having been observed elsewhere in 
North America [28]. Additional whole genome sequencing, SNP discovery and SNP 
screening as well as increased sampling will likely be needed to determine the origins and 
spread of F. tularensis in North America as a whole and Alaska specifically.
Interestingly, though there was no obvious geographic separation among the 
different Alaskan subclade A.I.Br.001/002 MLVA genotypes as they were all collected from 
Interior Alaska, the single Alaskan type A.II isolate was geographically separated from the 
other Alaskan isolates. The type A.II isolate (human) was isolated from the Matanuska 
Susitna Valley whereas most of the other isolates were from interior Alaska, where most
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tularemia cases occur. These two regions are separated by the Alaska Range, which might 
serve as a geographic barrier separating type A.II F. tularensis from other F. tularensis 
genetic types in Alaska. However, this hypothesis would need to be confirmed by 
genotyping more isolates from both geographic regions.
1.6 Conclusions
We have reviewed a history of F. tularensis in Alaska, beginning with its first 
isolation in a group of hare ticks in 1938 and progressing to its molecular characterization 
in 2011. Only limited studies have taken place within the state, there is still much to be 
learned about the ecology and epidemiology of tularemia, particularly in northern climates 
where it is endemic. We still do not know the reservoir in Alaska, though it is suspected to 
be hares or muskrats. We also do not know the prevalence of tularemia in most of the 
wildlife in the state. Overall the presented work suggests the need for renewed serological 
surveillance in both wildlife and humans to assess possible changes in Francisella 
prevalence in a rapidly changing Arctic. The current distribution of tularemia in Alaska is 
not well understood. While most cases are reported from Interior Alaska, the true 
distribution of cases in wildlife and humans is not known. In addition more molecular work 
is warranted to better understand the strains circulating in Alaska and assess potential for 
human infection associated with different host species. Transstadial transmission of 
tularemia should be addressed similar to work done in Sweden [30]. These steps will 
further increase our understanding of tularemia in Alaska and can guide public health 
surveillance and intervention.
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Table 1 .1 : Isolation of Francisella tularensis in Alaskan wildlife from 1938-1974
Year Host Location # Positive # Collected Reference
1938 Rabbit Tick Fairbanks 3 lots 3 lots 11
1953 Rabbit Tick Minto, Livengood, 
Fairbanks
3 lots 14 lots 12
1960 Tick (from 
ptarmigan)
Livengood 1 lot Unknown 24
1963 Red-backed vole Alaska Peninsula 1 217 15
1971 Varying hare Fairbanks 1 24 16
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Table 1 .2 : Prevalence of Francisella tularensis antibodies (titer >1:20) in Alaskan wildlife
from 1964 - 2000.
Year Host Location #Positive #Tested Reference
1964
1967-68
1975-82
1984­
2000
1988-91
Dairy cattle Tanana Valley 2 173
Barrow ground squirrel Tanana hills, Paxson 1 34
Red squirrel Interior, Paxson 9 111
Red-backed vole Interior, Paxson 2 120
Tundra vole Interior, Paxson 11 229
Porcupine Interior 1 2
Varying hare Interior, Paxson 3 60
Cliff swallow Interior 1 3
Bank swallow Interior 1 38
Common redpoll Interior, Paxson 1 15
Varied thrush Interior 1 4
Northern water thrush Tanana hills 1 3
American tree sparrow Tanana hills 1 10
Willow ptarmigan Tanana hills 1 2
Varying hare Eagle 1 29
Ground squirrel Denali highway 2 72
Red-backed vole Delta creek 1 376
Collared lemming Nome 1 25
Wolf Tok 1 15
Black bear Circle hot springs 2 4
Marten Eagle 9 26
Ermine Katella 1 31
Lynx Tok 1 4
Gray jay Manley hot springs 2 19
Northern raven Circle hot springs, 
Fairbanks
2 13
Northern shrike Glenn highway 1 1
Wolf Southcentral Alaska 16 67
Wolf Southcentral Alaska 1 6
Wolf Central Interior 8 32
Wolf Southern Interior 28 135
Wolf Eastern Interior 2 30
Wolf Western Interior 3 30
Wolf Northern Interior 7 48
Wolf Western arctic 5 75
Wolf Eastern arctic 2 45
Grizzly bear Kodiak island 3 77
Grizzly bear Alaska Peninsula 12 86
Grizzly bear Interior Alaska 13 40
Black bear Interior Alaska 13 40
Grizzly bear Seward Peninsula 4 40
Grizzly bear Noatak river drainage 12 87
Grizzly bear Arctic northwest 34 96
Grizzly bear Arctic northeast and 
central
15 54
14
18
19
20
17
25
Number of tularemia cases (n=19) reporting animal exposure
Figure 1.1: Number of human tularemia cases in Alaska reporting animal exposure.
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Figure 1.2: Neighbor-joining dendrogram of Alaskan and 34 additional subclade 
A.I.Br.001/002 F. tularensis isolates based upon MLVA data. The dendrogram was 
generated using neighbor-joining analysis of mean character differences using PAUP 
4.0b10 (D. Swofford, Sinauer Associates, Inc., Sunderland, MA). Bootstrap values >50, also 
generated using PAUP 4.0b10, are indicated and were based upon 1,000 simulations.
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CHAPTER 2:
Development and implementation of a broad-based polymerase chain reaction 
surveillance method for bacterial DNA in Alaskan wildlife tissues1 
Abstract
Current methods for bacterial exposure surveillance in animal blood and tissues include 
agent-specific antibody assays (usually for serum), culture, and agent-specific polymerase 
chain reaction (PCR) based assays. For most of these methods a specific disease agent is 
suspected or targeted before diagnostic or survey tests are conducted. In the current study, 
the development and implementation of PCR-based protocols to broadly survey (non­
targeted) bacteria using detection and sequencing of the bacterial 16S ribosomal RNA 
(rRNA) gene in opportunistically collected tissue samples of wildlife in Alaska are 
described. Quantitative real-time PCR was used to survey large sets of wildlife tissues 
(n=844). End-point PCR (n=454) was used on smaller sets of tissue samples. Of 1298 
samples, 108 had detectable PCR product; upon sequencing, 65 revealed interpretable 
sequences without the need for cloning, 47 of which are known or suspected pathogens. 
More sequences from potentially pathogenic bacterial species were detected in necropsy 
specimens, but likely contaminants originating from the gastrointestinal tract were 
detected as well. These results show that 16S rRNA gene-based PCR methods are 
potentially valuable tools for performing large-scale non-targeted surveillance for bacterial 
pathogens with recognition of limitations for strain or highly specific identification.
1 Hansen CM, Rember R, O'Hara TM, Huffer K. 2014. Development and implementation of a 
broad-based polymerase chain reaction surveillance method for bacterial DNA in Alaskan 
wildlife tissues. Prepared for submission to the Journal of Veterinary Diagnostic 
Investigation.
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2.1 Introduction
Current methods for establishing the presence of bacteria in tissue samples include (but are not 
limited to) targeted detection of specific taxa using polymerase chain reaction (PCR), and 
cultivation, which is considered the gold standard for disease diagnosis in many pathogenic 
species of bacteria.22,37 Additionally, specific reactive antibody detection (serology) can be used 
to detect current or past exposure to certain types of bacterial organisms. Limitations of these 
techniques include antibody cross reactivity and persistence of titers at detectable levels, which 
can make it difficult to diagnose an active (rather than historic) infection (serology);19,30,41 and 
prolonged time to obtain results (culture).19,41 It should be noted that most serum antibody 
detection and targeted PCR tests are agent-specific in that primers and antigens need to be 
selected and generated prior to performing diagnostics tests. There are multiple reasons for 
performing diagnostic tests on wildlife samples. The presence of or exposure to a specific 
organism may to be suspected, alternatively, there may be a compelling public health or food 
safety reason to monitor for that agent.
Serology allows for detection of active infection or past exposure, and is an invaluable 
tool for assessing exposure of populations to pathogens. However, determining if the organism(s) 
in question is present at sampling based on serology can be difficult.19,41 Typically early in an 
initial active infection (1-2 weeks) no specific antibody is detectable;13,30 the immunoglobulin M 
titer then begins to rise and can remain elevated during active or recent infection. The 
immunoglobulin G titer rises during convalescence and can remain high for many years or a 
lifetime.30 Antibody cross reactivity (e.g. Brucella and Yersinia) adds additional uncertainty to 
interpreting serologic results.9,11,25 Finally, antibody detection often relies on species-specific
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reagents, and not all assays are validated for the host species and associated bacteria for which 
they are used.17
The gold standard for diagnosing most active bacterial infections is culture and isolation 
of the causative agent.22,37 Culture confirms that live organisms are present in the tissue of 
interest. Culture methods are also used to compare biochemical and phenotypic characteristics of 
type strains to the isolate to be identified.7 However, due to diversity beyond that recognized by 
phenotypic identification schemes, an unambiguous identification cannot always be made, 
resulting in uncertain identification of the isolated organism or the need for follow-up tests to 
arrive at a final diagnosis. Some bacteria are fastidious, and diagnostic laboratories may not be 
equipped to culture them or may not attempt isolation.36 Organisms must also be viable in order 
to be successfully cultured. In most clinical specimens viability is typically not a concern, 
however, in poorly preserved tissue specimens, freezer archives, or when shipping long distances, 
this requirement may be problematic to achieve. Biosafety and biosecurity also must be 
considered when growing certain organisms (e.g. Bacillus anthracis, Francisella tularensis, 
Yersiniapestis), limiting diagnostic culture capabilities in some facilities.14,29
Polymerase chain reaction (PCR) is a commonly used and highly sensitive diagnostic tool 
that can rapidly detect or identify bacterial DNA through sequencing of amplicons. Multiplexing 
has led to tests that can diagnose multiple pathogens simultaneously.2 Further, PCR can be used 
to amplify any part of a bacterial genome, and commonly amplified segments include regions 
coding for plasmids, virulence factors, and membrane proteins.10,38 While these genes can be 
used to quickly identify certain pathogenic bacteria, none of these are common to most bacterial 
species. The use of a broad-based PCR surveillance method for bacterial DNA using a universal 
target is worthy of exploration, development, and ultimately strategic implementation.
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The 16S rRNA gene is common to all bacteria and encodes the 16S ribosomal RNA 
subunit. This gene is present in eukaryotic mitochondria as well, but its sequences are clearly 
divergent from bacterial 16S rRNA genes so that primers that amplify most bacterial 16S rRNA 
gene sequences will not amplify those from eukaryotic mitochondria.27 The bacterial 16S rRNA 
gene is approximately 1,542 base pairs in length and is critical to bacterial cell function. The 
gene contains regions that are highly conserved allowing for selection of broad-based primers. It 
also contains regions that are variable or hypervariable, providing opportunities for sensitive 
differentiation between bacterial taxa.5,20 Characterization of conserved and variable regions has 
made sequencing and analysis of the 16S rRNA gene a useful tool in bacterial phylogenetic
analyses.20
The 16S rRNA gene is used extensively in microbiological applications; most notably in 
the fields of microbial ecology and in determining phylogenic relationships of bacteria and 
archea.34,39 Additionally, PCR and sequencing of the 16S rRNA gene has been used in 
applications to identify human bacterial pathogens and is integral to the study of the human 
microbiome.12,18 Two studies examined the usefulness of broad ranged 16S rRNA targeted 
primers in the diagnosis of septic arthritis,3,31 and one examined an application to the field of 
human endodontics.15
A similar 16S rRNA gene PCR technique has been used to identify an animal pathogen,16 
and some veterinary diagnostic laboratories are using 16S rRNA gene amplification to identify 
bacteria in tissue samples, and data from some published surveillance efforts exist.8 It is 
important that we monitor wildlife populations for bacterial disease agents, as the majority of 
emerging human disease events originate in wildlife.21 Additionally, wildlife tissue sample 
collection is often done opportunistically and the amount of tissue collected can be limited.
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Therefore it is important to develop surveillance tools that are broad-based and can detect more 
than one type of bacterial disease agent.
In the current study, both endpoint and quantitative real-time PCR (qPCR) techniques 
and their application to disease surveillance in diverse taxa of wildlife are described. These 
techniques use universal primers that amplify the 16S rRNA gene from bacteria present in 
certain tissues that should not normally contain bacteria in healthy (uninfected) individuals (e.g. 
spleen, liver, lymph node, kidney, reproductive tract) as an indication of infection or 
contamination. The 16S rRNA gene PCR products from both end-point and qPCR were partially 
sequenced without cloning to determine what bacterial taxon was present in positive samples.
2.2 Materials and Methods
2.2.1 Sample Collection
A total of 1298 blood and tissue samples were utilized for this survey, see Table 2.1 for a 
summary of samples. Tissue samples from apparently healthy foxes were collected 
opportunistically from trappers and hunters throughout Alaska. Harbor seal samples (blood) were 
collected under the National Marine Fisheries Service (NMFS) scientific research permit #358­
1787 and sampling was performed with the approval of the Alaska Department of Fish and 
Game Animal Care and Use Committee (ACUC) approval (#07-16 modified/renewed). Dolphin 
samples (blood) were collected under NMFS scientific research permit #522-1785 and sampling 
was performed with approval of the Mote Marine Laboratory Institutional ACUC (#08-09-RW1, 
and 09-09-RW1). Ice seal samples (tissues) were collected under permit #932-1905-00/MA- 
009526 issued by the NMFS and the U.S. Fish and Wildlife Service (USFWS). California sea
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lion and harbor seal samples (tissue) were collected under the Alaska SeaLife Center’s National 
Oceanic and Atmospheric Administration/National Marine Fisheries Service (NOAA/NMFS) 
stranding agreement. Additionally, necropsy specimens from the Alaska Department of Fish and 
Game (ADF&G), University of Alaska Fairbanks (UAF) Animal Resources Center, and local 
veterinary clinics were included when opportunistically available. Samples collected included 
spleen, liver, lymph nodes, kidney, or any lesion where infection was suspected (i.e. granuloma 
or abscess). Samples were collected aseptically in the field or at UAF or ADF&G facilities by 
wildlife veterinarians or UAF veterinary staff (from the Animal Resource Center). The foxes 
from trappers in remote areas were submitted frozen and skinned, and abdominal and thoracic 
cavities remained unopened until sampling. Information on individual foxes was not provided, so 
time from skinning to freezing, and from freezing to sampling is unknown.
Since samples were collected opportunistically and culture was not performed as an 
integral part of this study, culture results were only present for some tissues. Cultures were 
performed on ADF&G samples by Colorado State University Veterinary Diagnostic Laboratories 
(Ft. Collins, CO, USA). There was one culture-positive tissue from a local veterinary clinic; this 
culture was performed at Fairbanks Memorial Hospital (Fairbanks, AK, USA).
2.2.2 DNA Extraction
The DNA was extracted from tissue samples using a commerical kita following manufacturer’s 
instructions. Samples were processed and analyzed as they were received. For large batches of 
samples (n>50), DNA was extracted using a 96-well kita. One formalin-fixed tissue from a local 
veterinary clinic was pre-treated by rinsing with phosphate buffered saline as per the 
manufacturer of the kit's instructions. The remaining samples required no pretreatment, as per
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manufacturer's instructions. To reduce the effects of potential PCR inhibitors,30,39 blood DNA 
was diluted 1:10 in nuclease free water; liver, spleen, and other tissues DNA were diluted 1:20 in 
nuclease free water prior to PCR.
2.2.3 Primers
Primers were selected flanking the 16S rRNA gene (see Table 2.2 for primer sequences) and 
were purchased from a commercial supplier.b Forward primer F2C and reverse primer R2C were 
used for the initial amplification reaction1 for both PCR and qPCR. This primer set amplifies an 
approximately 1,500 base pair portion of the 16S rRNA gene.
2.2.4 End-point PCR Reactions
End-point PCR reactions were performed on small batches of samples (n<48) as they arrived. 
Each PCR reaction contained one commercial ready-to-go PCR bead,c 18 pl of nuclease-free 
water, 10 pmol of each primer F2C and R2C, and 5 pl of diluted DNA template for a total 
reaction volume of 25 pl. Reactions were performed using a thermal cyclerd. Thermocycler 
settings for end-point PCR reactions were as follows: 3 minutes of denaturation at 94oC followed 
by 40 cycles of 30 seconds of denaturation at 94oC, 1 minute annealing at 65oC, and 1 minute 40 
seconds of extension at 72oC. A final 10-minute 72oC extension step was followed by hold at 
4oC until the reaction tubes were collected.
One positive and one negative control were amplified with each end-point PCR reaction. 
Escherichia coli (E. coli) DNA diluted in liver, blood, or spleen DNA (depending on sample type 
being analyzed) was used as a positive control. Blood came from an apparently healthy reindeer 
housed at the UAF Large Animal Research Station. Liver and spleen DNA was extracted from
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the liver and spleen of a disease-free rat housed at the UAF Animal Resources Center. Negative 
controls were selected to match the sample type being tested (blood, liver, or spleen DNA, as 
above). Some tissue samples were not commonly received (e.g. lymph node, kidney, 
uterus/testes); liver DNA was used as a negative control in these cases.
Five pl of PCR reaction product was run on 1% agarose gel using standard methods in 
Tris-acetate-ethylenediaminetetraacetic acid (TAE) buffer. Each gel was stained for 20 - 30 
minutes in TAE buffer containing ethidium bromide, imaged with ultraviolet light and the image 
captured with a digital camera. Positive samples showed a sharp band at 1,500 base pairs.
To estimate concordance between end point PCR and qPCR, 58 DNA samples that were 
positive (and yielded a sequence) with end-point PCR were run in qPCR as described below.
2.2.5 qPCR Reactions
Quantitative real-time PCR conditions were optimized separately from end-point PCR. For large 
batches of samples (n>48), and for concordance testing, qPCR reactions were performed. Each 
qPCR reaction contained 10.5 pl of master mix,e 7.5 pmol of each primer, 3 pl of nuclease free 
water, and 5 pl of diluted DNA template for a total reaction volume of 20 pl. The qPCR 
reactions were run either in a 384-well clear optical reaction platef on a commercial systemg or in 
96-well format on another commercial system.h
The thermal cycler settings for the qPCR assay were as follows: 10 minutes of 
denaturation at 95oC, 40 cycles of 15 seconds denaturation at 95oC, 30 seconds of annealing at 
60oC, and 2 minutes 20 seconds of extension at 72oC. This was followed by a melting curve; 
95oC for 15 seconds, 60oC for 15 seconds, and ramping to 95oC for 15 seconds. Fluorescence
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data was collected during each annealing phase and during the determination of the melting 
curve.
The qPCR data were analyzed using commercial software/ The qPCR reactions were 
considered positive if the cycle threshold (Ct) value was >2 lower than the lowest of the negative 
controls for each run. Dissociation (melting) curves were also used to interpret positive qPCR 
reactions: samples with a single sharp peak (in addition to meeting Ct criteria) were considered 
reliably positive.30 Peaks with a shoulder and double peaks were considered negative.
Positive controls consisted of DNA from either E. coli or Francisella tularensis (F. 
tularensis) subsp. novicida DNA diluted in either nuclease free water, liver DNA, blood DNA, or 
spleen DNA. Negative controls were the same as for end-point PCR. In addition to these 
negative controls, no-template-controls (nuclease free water) were included with every qPCR run, 
see detection limit section below.
2.2.6 qPCR Detection Limit and Dilution Factor Determination
E. coli (DH10B) was grown overnight in Luria broth (LB) at 37o C, and F. tularensis subsp. 
novicida (ATCC 15482) was grown in tryptic soy broth (TSB). The following day, 100 pl of 
each overnight culture was subcultured (in their respective medium) and grown to 1 (+/- 0.05) 
optical density at a wavelength of 650 nm on a spectrophotometer.k From these broth cultures, 
eight serial ten-fold dilutions were prepared. Ten pl of each dilution was plated on LB agar or 
TSB agar, respectively, and the plates were incubated overnight. The following day colony 
numbers were counted and colony forming units/ml were calculated. Additionally, DNA was 
extracted from 1 ml of each serial dilution using a commercial kita according to the 
manufacturer's instructions. Each extraction was eluted into 200 pl of final volume. The DNA
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concentration and purity of each standard was determined once using absorbance at 260 nm and 
the ratio of absorbance at 260 and 280 nm on one of two spectrophotometers,l,m The DNA 
extracted from these serial dilutions was used as standards in qPCR analysis and were used to 
calculate the detection limit in ng/reaction. The detection limit was defined as the smallest 
amount of bacterial DNA detectable in 95% of reactions.4
The presence of PCR inhibitors such as hemoglobin, glycogen, and fats30,39 necessitates 
the dilution of sample DNA. To determine the optimal dilution factor, serial dilutions of bacterial 
DNA in nuclease free water (E. coli or F. tularensis) were added to different dilutions of 
negative DNA control (1:1, 1:10, 1:20, 1:50, or 1:100) obtained from different tissues and 20 
replicate qPCR reactions were carried out to determine a 95% detection limit, as above.
2.2.7 Sequence Analysis
Primers and excess dNTPs were removed from the PCR products with a commercial kitn 
according to the manufacturer's instructions. Sanger sequencing of purified PCR products was 
performed by a commercial serviced Positive samples were first sequenced with one internal 
reverse primer (R1). If the sequence from that primer appeared reliable (high base quality scores) 
and if the initial sequence aligned with a potential pathogen in BLASTn, additional sequencing 
was performed using primer F1 to increase sequence coverage and quality. Only consensus 
sequences of overlapping regions of sequences were used for sequence identification of those 
sequenced with more than one primer. A complete list of all primers (PCR and sequencing) is 
shown in Table 2.2.
Sequence results were manually checked for quality by inspecting electropherograms, 
then trimmed using Ridom TraceEdit (http://www.ridom.de/traceedit/). Sequences with single
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peaks in each position on chromatograms were considered interpretable and were exported as 
text files for further alignment and analysis. Those sequenced with more than one primer (R1 and 
F1) were aligned using clustalw (http://www.ebi.ac.uk/Tools/msa/clustalw2/) using slow 
alignment type and default settings. A consensus sequence was generated for samples sequenced 
with more than one primer. The consensus sequence was defined as the sequence that was in 
common between two primers. If a discrepancy at a base pair was noted, chromatograms were 
examined and the base with higher calling score was selected to use in the consensus sequence. 
Sequences were entered into the National Center for Biotechnology Information (NCBI) Basic 
Local Alignment Search Tool (BLASTn) algorithm (http://blast.ncbi.nlm.nih.gov/) for 
identification. The 16S rDNA database was searched in BLASTn and the program was optimized 
for highly similar sequences. The BLASTn database was searched between June 2011 and June 
2013. A minimum cutoff identity score was not used, the highest identity sequence score was 
taken as the best match for the sequence obtained.
2.3 Results
To assess the sensitivity of amplification of the complete 16S rRNA gene by qPCR, a detection 
limit was determined by amplifying this gene from two different bacterial species. Extracted 
DNA from E. coli and F. tularensis subsp novicida was diluted in extraction products from 
different tissue matrices used in this study. The detection limit (Fig. 2.1) for E. coli DNA diluted 
in nuclease free water was 0.64 ng/reaction, which corresponds to 1.29 x 105 genomes 
(calculated). This method detected 0.4 pg/reaction of E. coli DNA (8 genomes) in 75% of the 
qPCR runs. Considering the dilution of samples, this (0.4 pg/reaction) corresponds to about 2.6 x 
106 genomes per ml in the original culture prior to DNA extraction. The 95% detection limit for
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E. coli DNA spiked in a 1:10 dilution of blood DNA was 4 ng/reaction, diluted in 1:20 liver 
DNA was 40 ng/reaction, and diluted in 1:20 spleen DNA was 4 ng/reaction. These detection 
limits correspond to 1.6 x 108, 3.2 x 109, and 3 .2 x 108 bacterial genomes per gram of original 
tissue when mass of tissue used for the extraction and dilutions are considered.
The detection limit for F. tularensis subsp novicida DNA diluted in water was 0.1 
ng/reaction (4.6x 104 genomes). This method detected 0.01 ng/reaction of F. tularensis DNA (5x 
104 genomes) in 50% of the qPCR runs. Diluted in 1:10 blood DNA the detection limit was 1 
ng/reaction (4.6 x 105 genomes), in 1:20 liver DNA was 10 ng/reaction (4.6 x 106 genomes), and 
in 1:20 spleen DNA was 10 ng/reaction (4.6 x 106 genomes). These 95% detection limits 
correspond to 9.3 x 107, 1.9 x 108, and 1.9 x 108 genomes per gram of original tissue. Similar 
detection limits were obtained for both F. tularensis and E. coli using two separate qPCR 
instruments (the same number of runs was not completed with each qPCR machine). Based on 
this detection limit data, it was determined that the optimal dilution factor for blood was 1:10, 
and for liver and spleen was 1:20.
A total of 225 wells of nuclease free water (no template control) were run throughout the 
course of this surveillance effort. In total, 62% (n=141) of the wells did not cross the baseline 
fluorescence threshold after 40 cycles. The average Ct value of the remainder of the no template 
controls (n=84) was 36.74 and none had a discernable melting curve. In addition, negative 
control samples (liver, spleen, and blood DNA) did not have sharp dissociation curves, therefore 
no negative control sample met our inclusion criteria for a positive sample.
Out of all PCR reactions (end-point and qPCR) (n=1298), 108 (8%) had detectable PCR 
product (Table 2.3). Of those 108 positives, 65 (60%) yielded interpretable sequences. Of the 65 
interpretable sequences, 48 sequences most closely matched sequences from obligate or
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opportunistic pathogens. The 17 sequences not considered pathogens were sequences that most 
closely matched soil bacteria (5 sequences had 97-99% identity matches with an uncultured 
Burkholderia identified from soil, GenBank accession JQ400905.1), or were best matched with 
uncultured clone sequences.
Among end-point PCR reactions (n=454), 83 (18%) had detectable PCR product (visible 
band at 1,500 bp), 52 of those (63%) had interpretable sequences. Of the 52 sequences, 47 were 
highly similar to known or opportunistic pathogens. Among qPCR reactions (n=844), 25 (3%) 
had detectable PCR product (Ct value more than 2 below lowest negative control, single peak 
dissociation curve), 13 of those (52%) had interpretable sequences. Of those 13 sequences, 1 
(8%) closely matched known or opportunistic pathogens. Table 2.4 lists closest matches for 
sequences obtained in this study. There were more poor quality or very short sequences in qPCR 
(n=12 or 50% of total sequences), relatively fewer with endpoint PCR (n=43 or 40% of total 
sequences). All sequences except for one (a 307 bp sequence with 90% identity to Clostridium 
nexile) had identity scores >95%. Fifty of 65 sequences (77%) obtained using R1 and/or F1 had 
identity scores >97%.
The health status of the host was determined by reviewing necropsy reports and 
veterinary medical records. Animals captured live, or from which samples were collected for 
herd health assessments were presumed to be generally healthy. Health status was listed as either 
infectious disease suspected (n=84) or infectious disease not suspected (n=1214). The 
qualification 'infectious disease' included all disease with infectious etiology, not just bacterial 
etiologies. Sequences were obtained from 30% of tissues where infectious disease was suspected, 
and from 3% of tissues where infectious disease was not suspected (Table 2.5). Sequences 
matched opportunistic or obligate pathogen sequences in 93% (27/29) of animals suspected of
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having infectious disease. In non-infectious disease suspects, this number was lower (58% or 
21/36).
Of those 58 samples that yielded good quality sequences using end-point PCR, 32 (55%) 
were positive using qPCR. Of those 32, 23 had interpretable sequences (72%). Of those, 17 
(74%) had matching sequences (genus and species), 3 more (13%) had matching sequences at 
the genus level, and 3 (13%) of the sequences did not match those obtained from endpoint PCR.
Concordance was evaluated in all cases where possible, but most tissue samples did not 
have culture results available, as samples were collected opportunistically. In several cases 
culture or targeted PCR did confirm the results obtained by the PCR-sequencing method in the 
tissues tested. In 4 cases F. tularensis sequences were obtained from samples (snowshoe hare 
liver and spleen) that had previously been confirmed positive with targeted (Francisella-specific) 
PCR.14 Additionally, a guinea pig lung sample that was culture-confirmed positive as Bordetella 
bronchiseptica yielded B. bronchiseptica sequences with both end-point and qPCR techniques. 
Three samples yielding Streptococcus uberis sequences were cultured and sequenced with 
Streptococcus specific primers and confirmed to be S. uberis. Finally, the same organism was 
confirmed in different tissues (from the same animal) in several instances. For example, in two 
moose, E. coli was cultured from lung and kidney, and the technique described in this study 
obtained E. coli sequences from the spleen and a lymph node, an additional moose lung was 
culture positive for P. multocida, and a P. multocida sequence was obtained using the universal 
primers described here. These results are consistent with what would be expected in a systemic 
infection.
There were occurrences of PCR results in the same or different tissues not matching 
results from culture. In a rabbit lung sample, E. coli was cultured but a sequence most closely
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matching Neisseria meningitidis was obtained using end-point PCR. In a mountain goat, lung 
and lymph node cultured Trueperella pyogenes, but Streptococcus uberis sequences were 
obtained using end-point PCR. In one mountain goat sample, mixed culture results (Enterobacter 
sp., Enterococcus, E. coli, Acinetobacter sp., Actinomyces, and Streptococcus) were obtained 
from both lung and lymph node, and the end-point PCR based technique described here yielded a 
sequence closely matching C. perfringens in the lung and S. uberis in the lymph node. In this 
case the C. perfringens is most likely a post mortem contaminant. Finally, in two moose E. coli 
was cultured from the lung and a C. sordellii sequence was obtained from one lymph node and a 
Streptococcus macedonicus sequence was obtained from the other’s lymph node using end-point 
PCR.
2.4 Discussion
This investigation has shown that broad-based 16S rRNA gene amplification and sequencing can 
be a valuable technique when used under the right circumstances for use in surveillance of 
bacteria that are potentially pathogenic in populations of wildlife. The PCR methods described 
here are particularly useful when infectious disease is suspected (i.e. necropsy or clinical 
specimens) in a normally sterile body tissue as a part of standard surveillance. In many cases, 
interpretable DNA sequences are obtained without the need for cloning or culture. In addition, 
both techniques are rapid and cost effective when applied to sampling efforts that involve large 
numbers of samples.
Previous studies have used similar 16S rRNA gene-based techniques to diagnose and 
identify pathogens in limited applications. None have used similar techniques for broad 
surveillance as applied here. As early as 1994, a PCR based assay was used to detect pathogens
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in cerebrospinal fluid.12 Two qPCR methods to amplify the 16S rRNA gene to determine the 
etiology of septic arthritis have been reported.3,31 Additionally, fluorescent dyes and melting 
curve analysis have been used to differentiate between 17 species of Gram-positive and Gram- 
negative bacteria23. Both Taq Man- and SYBR green-based qPCR techniques have been used to 
investigate bacterial concentrations in endodontic samples15. Finally, universal 16S rRNA gene 
primers have been used to amplify a Streptococcus phocae sequence from the uterine exudate in 
a spotted seal with pyometra16.
Various Ct cutoff levels can be utilized. Two previously mentioned qPCR studies3,31 used 
Ct cutoff values of >1 value below negative control, which is less stringent than the threshold in 
this study. The lower cutoff value used in the current study (>2 Ct values), while raising the 
detection limit, will decrease the number of false positives, and still identify clinically relevant 
bacterial loads. The detection limits in tissue determined in this study are higher than in agent 
specific qPCR assays.26,36 The higher detection limit may be due to the long PCR product (1,500 
bp, leading to less efficient PCR). In addition, the broad range of these primers can lead to 
amplification of small amounts of contamination resulting in a lower Ct value of negative 
controls. This lower Ct value of negative control samples will increase the amount of template 
DNA needed to cross the threshold at 2 Ct below the negative sample. Despite this adjustment, 
the detection limits obtained in this study do correspond with what is quantified in clinical
infection.7,24,29
Additionally, qPCR can be very sensitive, and at high cycle numbers most samples will 
cross the threshold, either due to amplification of fragments of eukaryotic DNA, or amplification 
of E. coli DNA in Taq polymerase.33 For this reason PCR using universal primers will not be as 
specific as agent-specific PCR for some bacterial taxa. Additionally, although the selected
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primers amplify a broad range of bacterial taxa, they are not strictly universal. Based on the 
Ribosomal Database Project probe match function (http://rdp.cme.msu.edu/probematch), the F2C, 
R2C primer pair will amplify 16S rRNA genes from 2,052 (of 3,662) complete bacterial 16S 
rRNA sequences in that database (accessed 12/4/2013).
The initial primer set used in this study amplified nearly the entire 16S rRNA gene. If a 
sample was positive, internal primers were used to amplify a smaller segment (approximately 
500 bp) of the gene. This shorter sequence (which includes 3 variable regions) was used in our 
identification. While a minimum of 500 bp of sequence is recommended for microbial 
identification (1,300 to 1,500 is ideal),20 the technique presented here allows for screening and 
preliminary identification of bacterial DNA in tissues. If 500 bp sequences are obtained and 
aligned with less than 1% ambiguity to strains available in public nucleotide databases, bacterial 
species can be identified with confidence.20 If further identification is desired (short or 
ambiguous sequences), further sequencing using universal or specific primers can be 
performed.16
Additionally, not all variable regions within the 16S rRNA gene are able to distinguish 
between different species of bacteria, and there is no single variable region that is able to 
distinguish among all bacteria.5 Regions V1, V2, and V3 (amplified by F1/R1 primer set) are 
able to distinguish between most pathogenic bacterial species, but were not able to distinguish 
between some Escherichia species, Shigella species, Klebsiella pneumonia, and Enterobacter 
aerogenes.5 If sequencing these regions reveals a member of one of these genera, additional 
sequencing may be required to attempt to identify to the species level. However, it should be 
emphasized that for the host species and geographic regions targeted for this surveillance the 
need for all positive samples to be identified to the bacterial species or strain level is not required.
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One would likely follow up when a linkage with a disease outcome is of management concern 
(public health, conservation) or scientific interest, an agent that may be emerging and worthy of 
further investigation, or a potential agent of biosecurity interest (foreign animal disease, 
bioterrorism). This is the value of the non-targeted, unbiased nature of this effort.
Previously published literature has not attained 100% concordance between culture and 
qPCR, or between species-specific targeted PCR and 16S rRNA gene qPCR, meaning that the 
same species is not always identified using multiple methods.3 Coinfection, or infection plus a 
contaminating bacterial organism are likely responsible for some of these differences. As 
expected, this study did not find 100% concordance between sequence data and the limited 
culture results that were available.
Additionally, this study examined concordance between end point PCR and qPCR on a 
limited number of available samples and did not arrive at 100% concordance. It is not surprising 
that differing PCR protocols, large amplicon size, and additional freeze-thawing (especially in 
conjunction with large amplicon size)31 may contribute to the somewhat limited concordance 
noted between end point and qPCR here. The end-point PCR and qPCR protocols developed 
during this study were optimized individually. Reagents used in each system are different and 
different optimal thermal profiles are to be expected thus limiting an interassay comparison of 
suitable rigor. These results do show, however, that both systems (end-point PCR and qPCR) can 
be adapted for use in a broad-based 16S rRNA gene PCR protocol.
It should be noted that only 3% of qPCR reactions (n=844) were determined to be 
positive based on Ct value and dissociation curve while 18% of end point PCR reactions (n=454) 
were considered positive based on presence of a clear band at 1,500 base pairs. This is expected, 
as the samples run in the qPCR protocol came from large collections of trapped or live sampled
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(presumably healthy) animals. Small batches of samples provided by the Alaska Department of 
Fish and Game were from necropsy specimens of sick or injured wildlife, thus it is not surprising 
that more of these samples contained bacterial DNA from that sample pool. This batching was 
based on logistics of sample receipt and timely testing and underscores the fact that the percent 
of positive samples in the two assays cannot be compared to assess performance of the two 
assays.
Also, it should be noted that not all samples from animals suspected of having an 
infectious disease yielded a positive PCR result. This is because animals suspected of having 
infectious disease of any etiology (viral, bacterial, or fungal) were included in this group. It is 
likely that some of these animals had viral, fungal, or noninfectious disease, which cannot be 
detected by this assay. Alternatively, animals might have been infected with a bacterial species 
whose 16S rRNA gene could not be amplified by the primer set used in this study. Finally, some 
of these results are simply false negatives. In most cases, data from culture or agent specific PCR 
assays were not available so we could not quantify a false negative rate. The lack of culture data 
is due to the opportunistic nature of sample acquisition that was performed in collaboration with 
a variety of individual and institutions.
The major advantages to this broad-based technique are that it is not agent-specific (non­
targeted), it is cost effective, fast, and has potential for very high throughput and relatively fast 
turnaround. Using the protocols developed for this study, the total cost per sample (including 
extraction, PCR, and sequencing) is less than $7.00 per sample. Including DNA extraction, 
positive/negative status can be obtained in less than 12 hours with either of these PCR techniques. 
If sequencing is available on-site, sequencing data takes several more hours. Sequencing was 
done off site in this study and results were available within 48 hours. The data presented here
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show that the universal primers used will amplify many obligate and opportunistic pathogen 16S 
rRNA genes but will also amplify the 16S rRNA genes from gastrointestinal or other 
contaminants. Additionally, with on site sequencing results are available less than 24 hours after 
sample acquisition. As such it is suited to large survey efforts utilizing a batch approach.
Similar to interpreting other diagnostic tests, context must be considered when 
interpreting sequences obtained with either of these PCR techniques. In some cases, a sequence 
represents an obligate pathogen (e.g. F. tularensis) and should be interpreted as an abnormal 
result, but many bacteria are opportunists and only cause disease when the host is compromised, 
such as when the immune system is impaired. In support of this, it is noted that more sequences 
from opportunistic pathogens (i.e. Clostridium species) were identified in animals that were not 
considered infectious disease suspects (Table 2.4). Similar to the gold standard of culture, 
sequencing results must be interpreted in the context of clinical and environmental factors.
One further limitation is the inability to easily resolve coinfection or contamination with 
multiple bacteria. Cloning PCR product into a plasmid vector and performing a restriction 
fragment length polymorphism assay or next generation sequencing would aid in resolving this 
issue, but that was not within the aims and scope of this investigation.
In conclusion, the two PCR-based techniques discussed above show potential use in non­
targeted surveillance and monitoring despite the limitations discussed above. The equipment 
required to perform end-point PCR is inexpensive and commonplace. qPCR equipment may be 
cost prohibitive. This approach (using one or both methods) would be most beneficial as an 
initial screening tool. Depending on sample size, end-point or qPCR could be used. Following 
initial PCR and sequencing; cloning, culture, or targeted PCR could be adopted, depending on
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the research or management question related to the surveillance efforts to obtain more specific 
results.
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Table 2.1. Summary of all samples included in this broad-based polymerase chain reaction 
surveillance project. Sequence obtained refers to the number of 16S ribosomal RNA sequences 
obtained from that species and tissue type.
Species Tissue n Sequences Infectious
obtained disease
suspecteda
American beaver (Castor canadensis) Lymph node 2
American black bear (Ursus americanus) Lymph node 2
Spleen 2 1
American mink (Mustela vison) Unknown 5 5
Arctic fox (Vulpes lagopus) Lymph node 1
Spleen 1
Arctic ground squirrel (Spermophilus parryii) Liver 1 1
Bottlenosed dolphin (Tursiops truncatus) Blood 11
California sea lion (Zalophus californianus) Blood 1 1
Lymph node 2 2
Canadian lynx (Lynx canadensis) Spleen 5 3
Caribou (Rangifer tarandus) Amniotic fluid 1
Blood 2
Joint fluid 1
Kidney 3 1 1
Liver 1
Lung 3 1 2
Lymph node 45 4 5
Mammary gland 1
Peritoneal fluid 1
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Table 2.1 continued
Spleen 53 3
Testes/uterus 11 1
Tonsil 1
Common raven (Corvax corvax) Spleen 1
Coyote (Canis latrans) Lymph node 2
Spleen 4
Dall sheep (Ovis dalli) Lymph node 5 3
Spleen 11 1
Domestic cat (Felis catus) Cystic fluid 1
Uterine material 1 1
Domestic dog (Canis lupus familiaris) Blood 1
Uterine material 1
Domestic guinea pig (Cavia porcellus) Lung 2 2
Ermine (Mustella erminea) Spleen 1
European rabbit (Oryctolagus cuniculus) Lung 1
Great-horned owl (Bubo virginianus) Spleen 2 1
Grizzly bear (Ursus arctos) Lymph node 3 2
Harbor seal (Phoca vitulina) Blood 144 5
Lung 2
Little brown bat (Myotis lucifugus) Lung 1
Spleen 2
Moose (Alces alces) Blood 27
Joint fluid 1
Lymph node 16 3
Spleen 11 3
6
1
1
1
1
1
1
2
1
1
2
7
4
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Table 2.1 continued
Unknown 1
Mountain goat (Oreamnos americanus) Lymph node 4 1
Spleen 2 1
Muskox (Ovibos moschatus) Lymph node 3 1
Spleen 4 2
Red fox (Vulpes vulpes) Liver 355 4
Lymph node 10
Muscle 1
Spleen 363 4
Red squirrel (Tamiasciurus hudsonicus) Spleen 2
Reindeer (Rangifer tarandus) Liver abscess 1 1
Ringed seal (Phoca hispida) Liver 5
Lung 1
Lymph node 25
Spleen 8
Testes 1
Thymus 3
Urine 1
Sitka black-tailed deer (Odocoileus hemionus) Lymph node 1
Snowshoe hare (Lepus americanus) Liver 7 3
Spleen 3 1
Unknown 1 1
Spotted seal (Phoca largha) Amniotic fluid 1
Liver 2
Lymph node 6
1
3
2
3
2
1
1
2
1
1
6
1
1
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Table 2.1 continued
Swainson’s thrush (Catharus ustulatus) 
Wolf (Canis lupus)
Wolverine (Gulo gulo)
Wood bison (Bison bison)
Woodchuck (Marmota monax)
Spleen 2
Urine 1
Liver 1 1
Blood 22
Kidney 7 2
Liver 3 1
Lung 6 1 1
Lymph node 15 1
Spleen 25 10 1
Liver 1
Lymph node 1
Spleen 2
Lymph node 1 1
Spleen 2 1 1
Spleen 1
aInfectious disease suspects were determined by reviewing necropsy reports and veterinary 
medical records. Infectious diseases of any suspected etiology were included. Numbers in this 
column are numbers of disease suspects.
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Table 2.2: Primers used for amplification and sequencing of the 16S ribosomal RNA gene
Primer Sequence (5’ -  3’) Direction Positiona Ref
F2C AGAGTTTGATCCTGGCTCAG Forward 8 1
R2C AAGGAGGTGATCCANCCRCA Reverse 1541 1
F1 GAGTTTGATCCTGGCTCAG Forward 9 26
R1 GWATTACCGCGGCKGCGG Reverse 500 12
a. Primer numbering relates to Escherichia coli 16S rRNA gene nucleotide position from the 5'
end of the primer
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Table 2.3: Overall polymerase chain reaction (PCR) and quantitative real-time PCR results. 
Positive PCR status was determined by the presence of a band at 1500 base pairs under 
ultraviolet light after staining with ethidium bromide. Positive qPCR status was determined by 
cycle threshold value (> 2 less than negative control) and by the presence of a single peak 
dissociation curve. Sequence indicates how many interpretable sequences were obtained from 
positive samples, pathogen indicates if the sequence was associated with an obligate or 
opportunistic pathogen.
PCR (n=454) qPCR (n=844) Total (n=1298)
Positive 83 (18%) 25 (3%) 108 (8%)
Sequence 52 (11%) 13 (2%) 65 (5%)
Pathogen 47 (10%) 1 (0.1%) 48 (4%)
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Table 2.4: Closest identities of sequences obtained by species and tissue. Sequence length is 
also provided. Organisms were identified by searching sequences using the National Center for 
Biotechnology Informations (NCBI) Basic Local Alignment Search Tool (BLAST).
Organism Species Tissuea Sequence Length Disease suspect
(Yes,No)
Bordetella bronchiseptica Guinea pig Lung 456 Yes
Clostridium Wolf Spleen 193 No
Clostridium bartletti Red fox Spleen 420 No
Clostridium butyricum Muskox Spleen 433 Yes
Clostridium haemolyticum Red fox Liver 444 No
Clostridium haemolyticum Caribou LN 415 No
Clostridium haemolyticum Caribou Kidney 438 No
Clostridium haemolyticum Wolf Spleen 315 No
Clostridium haemolyticum Wolf Spleen 399 No
Clostridium haemolyticum Wolf LN 407 No
Clostridium haemolyticum Wolf Spleen 224 No
Clostridium nexile Caribou Uterus 307 No
Clostridium perfringens Red fox Spleen 336 No
Clostridium perfringens Mountain goat Spleen 409 Yes
Clostridium perfringens Great horned owl Spleen 335 No
Clostridium perfringens Wolf Lung 248 No
Clostridium perfringens Caribou Spleen 436 Yes
Clostridium septicum Muskox LN 433 Yes
Clostridium sordellii Black bear Spleen 423 No
Clostridium sordellii Moose LN 420 Yes
Clostridium sordellii Grizzly bear LN 350 No
Clostridium sordellii Dall sheep LN 372 No
Clostridium sordellii Wood bison Spleen 318 Yes
Clostridium sordellii Dall sheep LN 426 No
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Table 2.4 continued
Clostridium sordellii Caribou LN 400 No
Escherichia coli Caribou Spleen 464 Yes
Escherichia coli Caribou LN 460 Yes
Escherichia coli Moose Spleen 449 Yes
Escherichia coli Moose LN 443 Yes
Francisella tularensis Snowshoe hare Spleen 455 Yes
Francisella tularensis Snowshoe hare Liver 438 Yes
Francisella tularensis Snowshoe hare Liver 506 Yes
Francisella tularensis Snowshoe hare Unknown 516 Yes
Fusobacterium spp. Wolf Spleen 104 No
Fusobacterium necrophorum Reindeer Liver abscess 429 Yes
Fusobacterium necrophorum Muskox Spleen 423 Yes
Fusobacterium necrophorum Guinea pig Lung 212 Yes
Neisseria meningitidis European rabbit Lung 270 Yes
Pasteurella multocida Moose Spleen 463 Yes
Pasteurella multocida Wolf Spleen 372 No
Pasteurella multocida Moose Spleen 358 Yes
Pasteurella multocida Caribou Lung 48 Yes
Pasteurella multocida Caribou LN 440 Yes
Streptococcus spp. Grizzly bear LN 151 No
Streptococcus uberis or ictaluri Dall sheep Spleen 216 Yes
Streptococcus uberis or ictaluri Dall sheep LN 313 Yes
Streptococcus uberis or ictaluri Mountain goat LN 444 Yes
Streptococcus macedonicus Moose LN 460 Yes
aLN = lymph node.
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Table 2.5: Sequences identified from tissues suspected of having infectious disease vs. tissues not 
suspected of having infectious disease.
Health Status n Interpretable sequences 
obtained
Suspect pathogen sequences obtained
Infectious disease suspect 84 29 27
Not infectious disease suspect 1214 36 21
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Figure 2.1. Detection limits for Escherichia coli and F. tularensis DNA in water and various 
tissue matrices. Solid squares indicate the average detection limit; open circles are the 95% 
detection limit (lowest concentration detected in 95% of quantitative real-time polymerase chain 
reactions) from 20 replicate runs. Error bars represent one standard deviation from the mean.
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Chapter 3 
Microbial infection as a source of embryo mortality in wild geese on the Arctic 
Coastal Plain of Alaska1 
Abstract
Whereas it is established that microbial infection is a source of embryo mortality in avian
eggs, much remains unknown regarding processes acting on hatchability in wild birds. To
address the role of bacterial infection as a cause of hatching failure in wild geese, we
monitored embryo development in a breeding population of greater white-fronted geese
[Anser albifrons) on the Arctic Coastal Plain of Alaska. During 2013, we observed mortality
of developing embryos and collected 36 apparently addled eggs for analysis. We used
standard culture methods and 16S rRNA gene sequencing to taxonomically identify
bacteria within collected eggs. A potentially novel species of Neisseria was isolated from 23
eggs, Macrococcus caseolyticus was isolated from 6 eggs, Streptococcus uberis and Rothia
nasimurium were each isolated from 4 eggs. Other bacterial taxa were isolated at lower
frequencies. Sequences of the 16S rRNA gene from our Neisseria isolate most closely
matched sequences from N. animaloris and N. canis [96-97%  identity), but phylogenetic
analysis suggests substantial genetic differentiation between egg isolates and known
Neisseria species. Additionally, we detected DNA from our Neisseria isolate in 44 of 63 egg
shell and nest swab samples, and in 4 of 28 cloacal swab samples. To assess the
pathogenicity of bacteria identified in contents of addled eggs, we inoculated our isolates of
Neisseria, Macrococcus, Streptococcus, and Rothia of varying concentrations into developing
1 Hansen CM, Meixell BW, Van Hemert CR, Hare RF, Hueffer K. 2014. Microbial infection as a 
source of embryo mortality in wild geese on the Arctic Coastal Plain of Alaska. Prepared for 
submission to Applied Environmental Microbiology.
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chicken eggs. Seven-day mortality rates varied from 60-100%, depending on species and 
dose of inoculum. Our results provide the first evidence of bacterially-induced embryo 
mortality in both wild geese and in the Arctic.
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Egg hatching failure causes a direct reduction in avian reproductive success and represents a cost 
to individual fitness. Despite the importance of egg hatchability to fecundity in birds, the 
mechanisms of embryo mortality remain poorly understood. Viability of avian eggs declines as 
the time to incubation onset increases (1) and prolonged exposure to ambient temperatures was 
traditionally considered the primary factor responsible for this pattern (1-3). However, recent 
research suggests that microbial infection may be an important proximal mechanism of embryo 
mortality (4-6). Investigations of microbial processes acting on bird eggs have been historically 
limited to cavity-nesting species in tropical climates (4, 5, 7), but more recently expanded to 
include temperate climates and open-cup nests (6, 8, 9).
Potentially pathogenic bacteria may be transmitted from the cloaca or reproductive 
organs of the nesting female, or may originate in the environment (e.g., nest bowl, 10) and enter 
the egg through the shell via pores. A variety of bacteria are present on eggshells shortly after 
laying, and subsequently grow to maximum abundance after three days (6). The presence of 
water on eggshells increases the abundance and diversity of bacteria present, and appears to play 
an important role in sustaining bacterial growth (11). In tropical environments, there is a positive 
relationship between trans-shell infection and humidity and temperature, and incubation inhibits 
bacterial growth and trans-shell penetration by reducing moisture on shells (5, 12). Furthermore, 
Godard et al. (6) reported considerably higher bacterial loads on eggs in open-cup nests as 
compared to those in cavity nests, likely as a result of increased exposure to water in the former. 
In contrast, recent research suggests that in temperate climates with cooler ambient temperatures, 
incubation may not hinder bacterial growth or penetration of eggshells (9, 13).
3.1 Introduction
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Less commonly, direct vertical transmission from the nesting female may result in 
infection or mortality of eggs. For example, there is no direct relationship between eggshell 
contamination with Salmonella enterica Enteritidis (SE) and contamination of egg contents, 
indicating that contamination may occur in the reproductive tract (14). Additionally, it is 
possible to isolate SE from the reproductive tracts of hens without fecal colonization (14). 
Contamination of the albumin is thought to occur as the egg passes through the oviduct. 
Campylobacter (reviewed in 15) and Mycoplasma (16) are less well studied, but are also thought 
to be vertically transmitted in avian eggs.
Hatching failure resulting from nonviable eggs has been commonly reported in 
temperate- and arctic-breeding waterfowl (17), however, the effects of microbial processes 
on waterfowl egg hatchability in northern regions have not been investigated. During the 
summers of 2011 and 2012, we identified at least one nonviable egg in approximately 10% 
of greater white-fronted goose (Anser albifrons) nests monitored on the Arctic Coastal Plain 
of Alaska (B. W. Meixell, unpublished data). While no previous nonviable egg rates exist for 
this nesting population, it is high compared to other populations of greater white-fronted 
geese (hereafter: white-fronted geese) in the Arctic (17). This, along with the abundance of 
nests in the area provided us the opportunity to investigate hatching failure in this 
population.
White-fronted geese breed in Alaska and Northern Canada and winter in the 
Southern and Western United States and Mexico (18). White-fronts have historically 
nested in low densities on the Arctic Coastal Plain of Alaska, but over the last 20 years have 
increased dramatically to become the most abundant nesting waterfowl species in the area 
(19). Furthermore, the Arctic Coastal Plain represents the northern extent of their breeding
74
range. White-front nests usually contain 3-6 eggs, with the female typically initiating 
incubation upon laying the penultimate egg [18). The egg mortality rate in this nesting 
population of white-fronted geese is high compared to that in other populations [17). While 
we do not know the cause of mortality in these eggs, based on the appearance of addled 
eggs, we hypothesize that some mortality is due to microbial infection.
The primary objective of this study was to assess microbial infection as a source of 
embryo mortality in white-fronted geese on the Arctic Coastal Plain of Alaska. Specifically, 
we sought to identify bacteria in contents of nonviable eggs, compare bacteria present 
within the cloaca of nesting females, in nest materials, and on eggshells to those found in 
the contents of nonviable eggs to assess potential sources, and inoculate embryonated 
chicken eggs with bacterial isolates from nonviable eggs to assess pathogenicity and 
establish causality.
3.2 Materials and Methods
3.2.1 Sample Collection. We monitored nests and collected samples between June 14 and
July 14, 2013 near Point Lonely, Alaska on the Arctic Coastal Plain [70° 54’ 45.49” N, 153°
14’ 28.82” W). We located white-front nests on foot. Each nest was assigned a unique ID
and its location was recorded with a handheld GPS unit. Each egg was candled to determine
incubation stage [20) and individually labeled with a number corresponding to laying
order based on egg staining [21); eggs were labeled on both ends with a permanent marker.
We visited nests every 4 -  7 days, at which time each egg was candled to identify embryo
mortality and estimate hatch date. Eggs that were noted to be addled [dead or not
developing with a history of containing a viable embryo) were collected and transported on
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foot to the field camp where contents were aspirated immediately. Eggs suspected of being 
infertile (no indication of development after a known period of incubation) were collected 
for comparison.
We collected egg contents by disinfecting the surface of the eggshell with 70% 
isopropyl alcohol, puncturing the air sac end and aspirating up to 2.0 mL of egg contents 
with a syringe and needle. Egg aspirate samples were transferred to sterile cryovials and 
aspirate and whole egg samples were kept at -20°C for up to 15 days until shipment to the 
University of Alaska Fairbanks (UAF), where they were stored at -50°C. A subset of eggs 
(n=7) collected in the 48 hours prior to leaving the field site were transported chilled on ice 
packs to UAF and cultured immediately upon arrival. Whole egg samples were thawed in 
the lab, opened and contents were examined visually to determine if eggs were addled or 
infertile.
We swabbed eggshells and nest contents to evaluate possible bacterial sources. We
used BD liquid Amies elution swabs (Eswab, BD, Franklin Lakes, NJ, USA) following the
manufactures instructions and swabbed approximately 1/3 of the surface of each eggshell
and multiple locations within the nest. During egg-laying, prior to incubation onset, we
selected a random sample of nests (n=12) from which we swabbed both egg shells and nest
contents separately. During incubation, we used a single swab to sample nest contents and
eggshells from nests identified as containing an addled or infertile egg; for comparison, we
also selected and swabbed eggshells and nest contents from nearby nests that contained
only viable eggs. We also obtained cloacal swab samples from a subset of nesting females
during late incubation. We captured birds on nests using bow-net traps (22) and collected
cloacal samples by inserting a swab approximately 10 mm into the cloaca. Swabs were kept
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cool on ice packs and transported on foot to the field camp where they were frozen at - 
20°C within a few hours of collection. Swabs were shipped frozen to UAF, where they were 
stored at -50°C until thawed for analysis.
All procedures were approved by the U.S. Geological Survey Alaska Science Center 
Animal Care and Use Committee and were authorized by U.S. Fish and Wildlife Service and 
Bureau of Land Management under permit numbers MB789758 and BLM AK FF095718, 
respectively.
3.2.2 Bacterial Culture and Identification. Sequencing and culture results from 3 
eggs collected during a pilot study in 2011 demonstrated that an approximately 350 base 
pair region of the 16S rRNA gene closely matched 3 bacterial genera [Neisseria, 
Staphylococcus, and Macrococcus), two of which were grown in culture [Staphylococcus and 
Macrococcus). However, some Neisseria species are fastidious and require specialized 
growth media [23); additionally, these eggs had been frozen for an extended time, possibly 
contributing to negative culture results. Using these preliminary sequence results, we 
tailored our culture protocols to target the putative Neisseria genus of bacteria while still 
allowing for Staphylococcus and Macrococcus to grow. Egg aspirates were plated on 
chocolate agar and blood agar [Remel, Lenexa, KS, USA) and incubated at 37°C for a 
minimum of 24 hours. Any plates that showed no growth after 24 hours were left in the 
incubator for up to 72 hours and checked for bacterial growth daily.
3.2.3 Microscopy. After isolation into pure culture, each colony type was Gram
stained using standard methods and photographed under a light microscope. For
transmission electron microscopy, bacterial cultures were grown in tryptic soy broth. The
culture was transferred to a Formvar® coated copper 200 mesh grid [SPI Supplies West
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Chester, PA) for one minute to allow bacteria to settle, and then culture was blotted off 
with filter paper. The bacteria that adhered to grids were stained with 1% phosphotungstic 
acid for one minute, which was removed by blotting with filter paper. Grids were washed 
with water and then air-dried. Images were taken on a JEOL JEM-1200EX TEM operated at 
85 kV and AMT Image Capture Software (version 5.4.2.247) and an Orca (Hamamatsu) 12 
bit 1024 by 1024 bit CCD camera.
3.2.4 DNA Extraction. In order to perform PCR, DNA was extracted from 25 ~L of 
egg aspirate samples using a Qiagen DNeasy blood and tissue kit (Qiagen, Valencia, CA,
USA) following manufacturer's instructions for animal tissue samples. DNA was extracted 
from 1 mL of overnight culture in tryptic soy broth following the manufacturer’s 
instructions for Gram-negative bacteria. DNA was extracted from swab samples by placing 
the liquid medium in a microcentrifuge tube and centrifuging at 5,000 x g  for 10 minutes. 
The supernatant discarded and the remaining pellet was resuspended in 180 ~L buffer ATL 
(tissue lysis buffer) and DNA as extracted using the Qiagen kits following the 
manufacturer's instructions for tissue extraction. DNA was stored at -50°C until analysis.
3.2.5 PCR and Sequencing. To amplify the bacterial 16S ribosomal RNA gene we
used PCR of egg direct aspirate and pure culture samples. To further genetically
characterize our Neisseria isolate, we performed additional PCR and sequencing of the
chaperonin 60 (cpn60) gene. All PCR reactions used illustra PuRe Taq ready-to-go PCR
beads (GE Healthcare, Pittsburgh, PA, USA) and were performed in an MJ Mini personal
thermal cycler (Bio Rad, Hercules, CA, USA). Positive and negative controls were run
alongside samples. E. coli DNA was used for positive controls for 16S rRNA and cpn60 gene
PCR reactions. Neisseria DNA isolated from one of the eggs was used as a positive control
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for Neisseria detection PCR. Nuclease free water was used as a negative control for all 
reactions. The E. coli [positive control) rRNA gene was amplified in all runs of our 16S 
rRNA and cpn60 gene PCRs. The E. coli rRNA gene was not amplified in any run of our 
Neisseria detection PCR. All negative controls were negative. We performed PCR for the 
16S rRNA gene using the "universal" primers F2C and R2C [44). Thermal cycling 
parameters were as follows: 94°C for 180s followed by 40 cycles of 94°C for 30s, 65°C for 
60s, 72°C for 100s. A final 10 minute 72° extension phase was followed by a 4° indefinite 
hold. These primers amplify the bacterial ribosomal RNA gene from a wide variety of 
bacterial species [13,388 bacterial 16S rRNA sequences as of 11/21/2013 using the 
Ribosomal Database Project's Probematch; http://rdp.cme.msu.edu/probmatch). Bacteria 
were identified via sequencing the PCR product and identified using the National Center for 
Biotechnology Information's basic local alignment search tool [BLAST).
Chaperonin 60 gene PCR was performed using the primers H529 and H530 [24) to 
further genetically characterize the Neisseria isolate. This gene is present in prokaryotes 
and eukaryotes and has a finer phylogenetic resolution than the 16S rRNA gene [reviewed 
in 24). Thermal cycling parameters were as follows: 94°C for 180s followed by 40 cycles of 
94°C for 30s, 50°C for 60s, 72°C for 60s. A final 10 minute 72° extension phase was 
followed by an indefinite 4° hold.
Additionally, we designed primers cpn2F [5'-AGCCGGTACCTGAAAAGTCA-3') and
cpn2R [5'-ACAGGCAGCAAATCACGGATA-3') to amplify a 304 bp portion of the cpn60 gene
in the novel Neisseria isolate detected in this study. This Neisseria-specific PCR was used on
our swab samples in an attempt to identify the source of the bacteria. In addition to our
broad-based 16S rRNA gene PCR to detect bacterial DNA, this Neisseria-specific PCR
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protocol was used on all originally obtained egg aspirate samples to detect Neisseria DNA 
in any other samples. Thermal cycling protocols were as follows: 94°C for 3 minutes 
followed by 40 cycles of 94°C for 30s, 68°C for 60s, 72°C for 30s. A final 10 minute 72° 
extension step was followed by an indefinite 4° hold.
Sanger sequencing of PCR product was performed by Elim Biopharmaceuticals 
(Hayward, CA). The 16S rRNA gene PCR products were initially sequenced using primer R1 
(5'-GWATTACCGCGGCKGCTG-3'), which obtains approximately the first 500 base pairs of 
the 16S rRNA gene (25). We used additional primers to obtain a full length 16S rRNA gene 
sequence for some of our Neisseria isolates: primers F1 (5'-GAGTTTGATCCTGGCTCAG-3') 
(26), F2D (5'-GATTAGATACCCTGGTAG-3') (27), and R2B (5'-
CTTGTGCGGGCCCCCGTCAATTC-3') (28). Chaperonin 60 sequences were obtained using 
primers M13F and M14B (29). Sequences were manually inspected using Ridom Trace Edit 
(www. ridom.de/traceedit) and trimmed to remove poor quality base scores at the ends of 
each sequence. Sequences were considered uninterpretable if more than one peak was 
present at each nucleotide position on the chromatogram. To improve coverage and 
generate consensus sequences for samples sequenced with multiple primers, sequences 
were aligned using Clustal omega (www.ebi.ac.uk/Tools/msa/clustalo/). Phylogenetic 
trees were generated after aligning and trimming sequences using SeaView 
(www.molecularevolution.org/software/alignment/seaview). Because cpn60 sequence 
data are not available publicly for Neisseria canis (a close relative of our isolate), we 
obtained and sequenced N. canis type strain H6 (ATCC14687) from the American Type 
Culture Collection (Manassas, VA, USA) for comparison.
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3.2.6 Embryonated Egg Infections. In an attempt to fulfill Koch's postulates we 
inoculated chicken embryos with the bacteria isolated most commonly from our eggs as 
described by Nix et al. [30). Two of our novel Neisseria isolates and one isolate each of 
Macrococcus caseolyticus, Streptococcus uberis, and Rothia nasimurium were grown to the 
late log phase [optical density at 600 nm, 0.95 to 1.05) and diluted in phosphate buffered 
saline [PBS) for injection. Inoculating doses were determined through serial dilution and 
colony-forming unit [CFU) counts, five 10-fold dilutions were prepared from each isolate. 
One-day-old fertilized White Leghorn chicken eggs obtained from Charles River Labs 
[Wilmington, MA) were incubated at 37°C with high humidity and mechanically tilted to a 
45° angle every hour for seven days prior to infection and throughout the experiment. Five 
eggs were inoculated with each dilution of each strain [125 total eggs) and 9 control eggs 
were inoculated with PBS. Eggshells were punctured at the air sac end and 100 pL of 
inoculum was injected under the chorioallantoic membrane with a tuberculin syringe. After 
injection, the shells were sealed with a drop of Elmer’s® School glue [Elmer’s Products Inc. 
Columbus, OH).
The viability of the embryos was determined via candling and eggs were checked 
daily starting one day after infection for 7 days [i.e., when embryos were 14 days old). We 
scored embryos that lost the integrity of their capillary networks as dead [30). A sample of 
egg contents from each egg was plated on tryptic soy agar the day that they died, or at day 
7 post-infection for survivors and controls. All plates were checked daily for bacterial 
growth for up to 72 hours. Bacterial organisms recovered were Gram-stained and 
sequenced as described above. The mean survival times of chicken embryos infected with
different inocula were determined with Kaplan Meier survival curves.
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3.2.7 Histopathology. One embryo each from eggs that died at 3, 4, and 5 days 
post-infection with the novel Neisseria isolate, and one viable control embryo were sent to 
the University of Minnesota Veterinary Diagnostic Laboratory for histopathologic 
examination.
3.3 Results
3.3.1 Samples Collected. We monitored a total of 237 white-front nests during the 2013
field season and identified at least one nonviable egg (addled or infertile) in 41 nests (17%).
The majority of these nests contained a single addled egg (58.5%), whereas some nests
contained a single infertile egg (9.8%), multiple addled eggs (9.8%), multiple infertile eggs
(12.2%), or a combination of addled and infertile eggs (9.8%). In all, 36 addled eggs were
collected from 28 nests and 17 infertile eggs were collected from 13 nests. The contents of
addled eggs differed markedly from infertile eggs in visual appearance (Figure 3.1). Addled
eggs showed failure of the perivitelline membrane resulting in loss of the distinction
between yolk and albumin, and their texture varied from thin and serous to thick and
caseous. The color of addled egg contents varied from yellow to green to grey in color while
infertile eggs were characterized by a distinct yellow-to orange yolk and clear albumin.
3.3.2 Microbiology, PCR and Sequencing. Thirty of 36 aspirate samples from
addled eggs were PCR positive for the bacterial 16S rRNA gene. Of those positives, 12
yielded sequence information and the remainder contained double peaks at most base
pairs and were considered uninterpretable (Table 3.1). Six of 17 aspirate samples from
infertile eggs were PCR positive for 16S rRNA but none yielded sequence information.
Twenty-six of 36 addled eggs had at least one type of colony growth on blood and/or
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chocolate agar and all 16S rRNA sequences generated from pure cultures were 
interpretable [Table 3.2). From these combined egg aspirate and culture PCRs, 23 
Neisseria-like sequences were identified; 21 from pure cultures and 2 from egg aspirates 
[eggs that had no growth on blood or chocolate agar). Macrococcus caseolyticus was 
identified in 6 eggs and Streptococcus uberis and Rothia nasimurium were each identified in 
4 eggs; Shigella flexneri and Staphylococcus sciuri were each identified in 2 eggs, and the 
remaining 5 bacterial species were each detected in a single egg. Most eggs from which 
multiple bacterial sequences were recovered after culture yielded uninterpretable 
sequences on initial aspirate PCR.
After development of a PCR assay to detect the cpn60 gene in our specific Neisseria 
isolate, the protocol was used on egg aspirate samples. All samples, in which we cultured 
and/or obtained a Neisseria sequence, were positive for Neisseria DNA using this new 
protocol. Four additional eggs from which we obtained different bacterial isolates also 
tested positive for Neisseria DNA. Two addled eggs with no bacterial growth and which 
tested negative for the bacterial 16S rRNA gene were additionally positive for Neisseria 
DNA using this new PCR protocol. Finally, four infertile eggs from which no growth and no 
bacterial 16S rDNA was identified did contain Neisseria DNA according to this new PCR 
protocol.
3.3.3 Cloacal and Nest Swabs. We developed a PCR to detect the Neisseria isolate
found during the 2013 field season. A total of 91 swab samples were analyzed [Table 3.3).
Of the 24 swabs collected prior to the onset of incubation [12 sets of an eggshell and a nest
swab), in 4 sets both eggshell and nest material tested positive for DNA from our Neisseria
isolate. However none of those was from a nest that later contained an addled egg from
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which Neisseria was isolated. One preincubation nest swab was positive for Neisseria DNA, 
and that nest later contained an addled egg from which Neisseria was isolated; the eggshell 
swab from that sample was negative for Neisseria DNA.
Some samples collected during incubation were positive for Neisseria DNA as well. 
Of swabs collected from nests containing addled eggs (n=24), 20 were positive for Neisseria 
DNA. 15 of those nests contained eggs from which Neisseria was isolated. Neisseria DNA 
was also identified in the nest material of all 15 nests that were swabbed as controls (not 
containing an addled egg).
Twenty-eight cloacal swabs were assayed for Neisseria DNA, these samples were 
collected at hatch from white-fronted goose hens. Four swabs were positive for Neisseria 
DNA, but none were from hens that had been incubating an addled egg from which 
Neisseria was isolated. We did, however, identify Neisseria-addled eggs in the nests of two 
hens whose cloacal swabs tested negative for Neisseria DNA.
3.3.4 Morphology. Gram stain revealed Gram-negative cocci. Transmission electron 
microscopy of the Neisseria--like organism revealed the morphology of the culture as 
diplococcic (Figure 3.2) with a diameter of approximately 500nm.
3.3.5 N eisseria  Phylogenetics. BLAST alignment results using partial 16S rRNA 
gene sequences identified N. canis and N. animaloris as the closest matches to our Neisseria 
isolate. The highest identity score for any of our isolates is 97%. A neighbor-joining tree 
including our 23 Neisseria-like isolates and other Neisseriales sequences from GenBank is 
shown in Figure 3.3 and shows that our isolates cluster together and show some genetic 
variation.
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Given the frequency of the occurrence of Neisseria-like bacteria in addled eggs 
[isolated and/or sequenced from 23 of 36 addled eggs) and the unclear species distinction 
of these bacteria, we placed additional focus on characterizing this organism. We 
sequenced the cpn60 gene from all putative Neisseria isolates, and obtained full-length 16S 
rRNA gene sequences from a subset of our isolates.
The phylogenetic tree derived from cpn60 sequences obtained from our isolates and 
from publicly available sequences [Genbank) [Figure 3.3) shows a cluster of these isolates 
with some variability, though this tree locates our isolates at about equal distance to N. 
wadsworthii and N. canis.
Finally, a tree constructed from full length [1298-1448 bp) 16S rRNA gene 
sequences of our isolates and others in the class betaproteobacteria clearly show our 
isolates in a distinct cluster, but nearest to Neisseria canis and others in the family 
Neisseriales [Figure 3.4). Additionally, all of our full-length 16S rRNA gene sequences had 
<97% identity scores. Bacteria sharing <97% 16S rRNA base pairs generally are considered 
to be different species [31).
3.3.6 Embryonated Egg Infections. The majority of embryos from eggs infected 
with the Neisseria isolates died by day 7 post infection although there was some indication 
that survival varied by inoculation dose; all embryos inoculated with greater than 10,000 
colony forming units [cfu) died by day 5, while 10% of embryos inoculated with 1,000 cfu 
survived 7 days post-infection, and 30% of eggs infected with 100 cfu survived the 7-day 
trial [Figure 3.5). All eggs inoculated with S. uberis [100-104 CFU) died by day 4 post­
infection. All eggs inoculated with 106 CFU of R nasimurium died by day 4; 105 and 106 CFU
died by day 5, 103 CFU died by day 4, and 1 egg inoculated with 102 R. nasiumrium survived
85
until 7 days post-infection. All eggs inoculated with 106 CFU of M. caseolyticus died by day 5. 
Eggs inoculated with all other dilutions of M. caseolyticus (105-102) died by day 7 post­
infection. All control eggs survived inoculation with PBS.
Histopathology of embryos inoculated with putative Neisseria showed marked 
underdevelopment, tissue degeneration and necrosis. Organ, tissue, and cellular details 
were obscured by cellular infiltrates. Bacterial colonization with Gram-negative cocci was 
present in 2 of 3 embryos.
3.3.7 Sequence Accession Numbers. The sequence data from this study have been 
deposited in GenBank. Putative Neisseria isolate 16S rRNA sequences are under accession 
numbers KF995745-KF995749, KF999688-KF999690, KJ596479-KJ596481, KF999694- 
KF999695, KJ596482, and KF999697-KF999705. Putative Neisseria isolate cpn60 
sequences are under accession numbers KJ508837-508856. Sequences obtained using 
apparent Neisseria-specific PCR (cpn60) are under accession numbers KM233718- 
KM233764. Other isolate sequences are under accession numbers KJ652676-KJ652699. 
Neisseria canis cpn60 sequence is GenBank accession number KJ872773.
3.4 Discussion
Using culture and PCR, we detected a total of 11 species of bacteria in addled white-fronted 
goose eggs. The most prevalent was a single species in the Neisseria genus that was isolated 
from 21 addled eggs, and 16S rRNA gene sequences corresponding to this Neisseria isolate 
were recovered from 2 additional eggs that had no apparent bacterial growth. Using a PCR 
protocol developed specifically to detect this Neisseria isolate, we detected DNA in an
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additional 6 addled eggs and in 4 infertile eggs. We also detected Macrococcus, 
Streptococcus, Staphylococcus, and Rothia in our samples.
Bacteria from eggshells and egg contents have been isolated from a range of other 
avian species. Ruiz-de-Castenada [10) described microorganisms on the eggshells of 
flycatchers in a temperate environment. They did not detect any Gram-negative cocci on 
eggshells, but did find Serratia fonticola, which was isolated from the contents of one egg in 
our study [Table 3.2). Another study focused on nonviable raptor eggs in Canada and found 
that most had heavy bacterial growth; E. coli, Streptococcus and other organisms were 
isolated from the contents of addled eggs [32). Finally, Pinowski [33) found that 70% of 
sparrow [Passer domesticus and P. montanus) eggs that did not hatch contained bacteria, 
including E. coli, Staphylococcus spp., Streptococcus spp., and Serratia fonticola. Thus, the 
presence of Streptococcus and Staphylococcus bacteria in addled eggs appears to be 
common. It is perhaps unusual that we did not identify E. coli bacteria in our samples given 
that it has been found in all previous studies. Our identification of Neisseria as the 
predominant bacteria isolated from addled eggs appears to be novel.
While Neisseria has not been associated with egg contents in wild bird populations, 
previous reports of "goose gonorrhea" in domestic geese in Hungary may be relevant [34, 
35). These reports describe a disease of the phallus and cloaca; pathology includes swelling 
and mucosal reddening, necrotic inflammation, prolapse, and sometimes partial loss of the 
phallus. Afflicted domestic goose flocks had decreased feed intake, decreased egg 
production, and increased sterility [34). Pataky et al. [35) described the organism 
associated with goose gonorrhea as a Gram-negative coffee-bean shaped mono- or
87
diplococci that is 0.5 ^m in diameter placed the organism in the Neisseria genus. Further, 
three isolates whose DNA sequences most closely matched N. musosa (100%), N. canis 
(96%), and N. meningitidis (96%), were isolated from duck feces in New Zealand (36).
We did not isolate bacteria or amplify the bacterial ribosomal RNA gene from all 
collected addled eggs. Eight eggs confirmed addled by visual inspection in the laboratory 
did not demonstrate any bacterial growth, and were either PCR negative for 16S rRNA, or 
had weak uninterpretable sequences. Two of those eggs did contain detectable Neisseria 
DNA as evidenced by a PCR developed to detect our isolate. Our incapacity to detect all 
Neisseria in eggs initially may be due to the presence of other bacteria in some of those 
samples that may have overgrown the Neisseria in culture, or the presence of Neisseria at 
very low levels, or the possibility that Neisseria had died during transport from the field. 
Additionally, DNA may have been present at very low levels and may have been below the 
detection limit of our broad-based 16S rRNA gene PCR protocol.
Despite the increased detection of Neisseria with our new PCR protocol, not all 
addled eggs yielded bacterial DNA or bacterial growth. This implies that other causes may 
be responsible for some of our documented embryo mortality, or that our diagnostic 
sensitivity (culture and PCR) was less than 100%. It is plausible that only one compartment 
of an egg is infected (yolk, albumin, embryo), and due to the limited volume aspirated, 
bacteria may not have been sampled. For example, Cook et al. (4) isolated bacteria from 
different egg compartments, and not all species were present in the same compartments. 
Thus, microbial infection may be the primary cause of embryonic mortality, but we may
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have underestimated the prevalence rate for some of the bacteria we identified and other 
taxa of bacteria may be present in our samples but not detected via our methods.
Most studies of avian embryo mortality from microbial pathogens have focused on 
trans-shell infection as the primary route of transmission [4-7). However, it has also been 
shown that some species of bacteria [e.g., Salmonella, Campylobacter, Mycoplasma) may 
infect eggs prior to laying via direct contamination of reproductive organs [15, 16, 37). We 
attempted to identify the source and possible route of transmission of the most commonly 
isolated bacteria [a Neisseria species) by analyzing swab samples from eggshells, nest 
contents, and cloacae of nesting females. Our results indicate that the Neisseria isolate 
found in most addled eggs is widespread in the nest environment [i.e. nest materials and 
egg shells) and infection of eggs may occur post laying. However, we also detected 
Neisseria in some cloacal swab samples implying that eggs may have been infected prior to 
laying. In two instances, cloacal swabs were negative for Neisseria DNA, but Neisseria- 
addled eggs had been identified in their nests earlier in the nesting season. This may mean 
that hens are infected, pass the bacteria to their eggs, and can clear the infection 
themselves, or that the bacteria is originating higher in the reproductive tract.
Given these results, our data are inclusive in terms of identifying the potential 
source of the Neisseria we isolated from eggs, and it is possible that multiple modes of 
transmission are occurring [as occurs with Salmonella). Further, not all eggs associated 
with contaminated nests or females were addled, implying that transfer to eggs is not 
ubiquitous or that eggs tend to be infected with relatively low quantities of bacteria. Based 
on our inoculation study, the LD50 for our Neisseria isolate is low [less than 100 CFUs), but 
some eggs infected at low doses did survive.
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Sequence data suggest that the Neisseria species isolated in this study has not 
previously been described. Phylogenetic analysis using 16S rRNA and cpn60 gene 
sequences suggest that it belongs to the Neisseria genus, but species distinction is unclear. 
None of our full-length 16S rRNA gene sequences are more than 97%  similar to existing 
sequences, which traditionally has been the cutoff for the species level (31). Therefore, our 
isolates appear to be distinct from other described species. We also detected some 
variability between the isolates from addled eggs, meaning that this is not recent expansion 
of a single clone. This pattern, along with our alignment scores, suggests that the Neisseria 
we have isolated may be a previously undescribed species and deserves further 
investigation.
The family Neisseriales currently contains 32 genera that occupy a wide range of 
habitats including oral, gastrointestinal, and reproductive tracts of many species (reviewed 
in 38). Two well-known human pathogens do exist in the genus (N. gonorrhoeae and N. 
meningitidis), and other species are occasionally isolated from a variety of sources (39). 
Organisms that are closely related to our Neisseria isolate tend to be oral and 
gastrointestinal commensals, but are sometimes associated with disease. Neisseria canis is 
often associated with periodontal disease in dogs (40). Neisseria weaveri and N. animaloris 
(and other species) are sometimes isolated from animal bite wounds (41, 42). A species 
with a similar sequence to our isolate was isolated from the liver of a sheldrake (Tadorna 
tadorna) that was found dead in China (43). The probable source of the Neisseria isolates 
we identified is unclear, but other species in the genus tend to be oral and gastrointestinal 
tract commensals, so it is likely that this isolate is originating from the hen in some way.
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In addition to our commonly identified Neisseria isolate, three other species of 
bacteria were isolated from >3 addled eggs. The first, Macrococcus caseolyticus, [isolated 
from 6 eggs) is typically found in cow's milk and is generally not considered a pathogen 
[44). There are no reports of any Macrococcus sp. in bird eggs. The second, Streptococcus 
uberis, [isolated from 4 eggs) is a well-known cause of mastitis in cattle [45), but has not 
previously been isolated from bird eggs. However, there are reports of other Streptococci 
being isolated from eggs [4, 32). Finally, Rothia nasimurium [isolated from 4 eggs) is most 
commonly isolated from the upper respiratory tract of pigs and mice [46). While other 
species in the Rothia genus occasionally cause disease in humans [47), there are no reports 
of any Rothia species being isolated from bird eggs. All of these bacterial isolates are or are 
related to organisms that are most commonly commensals or opportunistic pathogens 
[except S. uberis), and are typically found in animals. Accordingly we suspect that the 
ultimate source for all these bacteria is the birds themselves. Given that white-fronted 
geese spend the winter months in the southern United States, it is plausible that these 
isolates originated there, perhaps from contact with domesticated animals.
Our results demonstrate that embryo mortality in greater white-fronted goose eggs
on the Arctic Coastal Plain of Alaska is likely caused by bacterial infection. This study
provides the first evidence of microbial-induced hatching failure in wild geese and in an
Arctic ecosystem. We detected a potentially novel species of Neisseria in numerous addled
eggs that were previously observed in normal embryo development, and in no infertile
eggs. Further, inoculations of bacterial isolates into developing chicken eggs provided clear
evidence of this organism’s pathogenicity. We also isolated and demonstrated mortality
potential of three other bacterial species: Macrococcus caseolyticus, Streptococcus uberis,
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and Rothia nasimurium. Future research should focus on source and route of infection, 
possible reservoirs, and geographic extent of Neisseria and other bacterial sources of 
embryo mortality.
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Table 3.1: Partial 16S ribosomal RNA gene PCR results from egg aspirate samples. Primers 
F2C and R2C were used for PCR; primer R1 was used for sequencing. Sequences with more 
than one peak at each base pair were considered uninterpretable and likely resulted from 
more than one species of bacteria being present in each sample.
n Status PCRresult BLASTn Matcha rdp Matchb
6 Addled + Neisseria animaloris or N. canis [95­96% )
Bacterium "New Zealand A" 
100% )
[99-
5 Addled + N. animaloris (96-97% ) Bacterium "New Zealand A" 100% )
[99-
1 Addled + Helcococcus ovis [91% ) H. ovis [68%)
18 Addled + Uninterpretable Uninterpretable
6 Addled - - -
6 Infertile + Uninterpretable Uninterpretable
11 Infertile - - -
a. National Center for Biotechnology Information nucleotide BLAST [Basic Local Alignment 
Search Tool; BLASTn), http://blast.ncbi.nlm.nih.gov/Blast.cgi
b. Ribosomal database project [rdp) seq match, http://rdp.cme.msu.edu/seqmatch.
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Table 3.2: Pure culture partial 16S rRNA gene BLASTn sequence matches for all isolates obtained from addled eggs. Primers 
F2C and R2C were used for PCR; primer R1 was used for sequencing.
n BLASTna Match Isolate 1 BLASTn Match Isolate 2 BLASTn Match Isolate 3
5 Neisseria animaloris or canis (95-96% )
3 N. animaloris (96-97% )
3 N. animaloris (96-97% ) M acrococcus caseolyticus (98% )
2 N. animaloris (96-97% ) Streptococcus uberis (99-100% )
2 N. animaloris (97%) Rothia nasimurium  (98-99% )
1 N. animaloris or canis (96% ) R nasimurium  (97%) Ottowia thioxydans (96%)
1 N. animaloris or canis (97% ) R nasimurium  (97%) Moraxella cuniculi (98%)
1 N. animaloris or canis (96% ) M. caseolyticus (97%)
1 N. animaloris (96%) M. caseolyticus (98%) Staphylococcus sciuri (99%)
1 N. animaloris (96%) Paracoccus yeei (98%)
1 N. animaloris or canis (96% ) Stenotrophom onas rhizophila (100% )
1 S. uberis (100% ) S. sciuri or vitulinus (99% )
1 M. caseolyticus (98% ) Serratia fonticola  (99%)
1 S. uberis (100% ) Shigella flexneri (99%)
1 S. flexneri (99% )
11 No growth
a. National Center for Biotechnology Information nucleotide BLAST (Basic Local Alignment Search Tool; BLASTn), 
http: //blast.ncbi.nlm.nih.gov/Blast.cgi
Table 3.3: Greater white-fronted goose [Anser albifrons) bacteriologic swab samples 
collected during lay [preincubation), incubation, and at hatch at Point Lonely, Alaska, in 
2013. The PCR assay conducted amplifies a 304 bp segment of the chaperonin 60 gene and 
is specific for our Neisseria isolate. Addled with Neisseria indicates the number of eggs from 
that subset that were identified as addled, and where our Neisseria isolate was identified in 
egg contents.
Preincubation Samples
Nest/egg combinations [n=12 nests, 12 eggs) n Addled with Neisseria
Egg and Nest PCR + 4 0
Egg - and Nest + 1 1
Egg and Nest PCR - 7 0
Incubation Samples [egg and nest material)
Swabbed with addled egg in nesta [n=24)
PCR + 20 15b
PCR - 4 2
Swabbed as control [no addled egg, n=15)
PCR + 15 0
PCR - 0 0
Hatch Samples
Cloacal swabsc [n=28)
PCR + 4 0
PCR - 24 2
a. Two nests had been swabbed with preincubation samples
b. One nest had been swabbed with preincubation samples
c. Two cloacae were from nests that had been swabbed with preincubation samples
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Figure 3.1: An example of the contents of an addled egg (a) compared to an infertile egg (b). 
Eggs were collected at Point Lonely, Alaska, during the summer of 2013.
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Figure 3.2: Gram stain performed with standard techniques (a) and showing small Gram- 
negative diplococci. Transmission electron micrograph (b) of one of our Neisseria isolates 
showing approximately 500 nm diplococcic organisms with spherical to coffee bean shapes.
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KJ508855 KH1567 
KJ508854_KH1565 
KJ508853 KH1511 
KJ508852_KH1509 
KJ508851_KH1504 
KJ508850 KH1503 
KJ508847_KH1500 
KJ508845_KH1498 
KJ508841_KH1491 
i KJ508839_KH1485 
I KJ508835 KH1472 
KJ508843_KH1495 
h KJ508840 KH1490 
KJ508842_KH1494 
|- KJ508837 KH1479 
KJ508836 KH1473 
KJ508856_KH1570 
KJ508849_KH1502 
KJ508848_KH1501 
KJ508846_KH1499 
KJ508844_KH1497 
KJ508838 KH1483 
KJ508834_KH1471 ”
Neisseria_canis_ATCC14687
------------------ Neisseria_weaveri_LMG5135
Neisseria_macacae_ATCC33926
77
100
95
Point Lonely 
Neisseria isolates
74  Neisseria_meningitidis_ATCC13091
Neisseria_polysaccharea_ATCC43768 
NeisseriaJactamica_ATCC23970 
Neisseria_gonorrhoeae_NCCP11945
 Neisseria_cinerea_ATCC14685
Neisseria_wadsworthii_9715
 Simonsiella_muelleri_ATCC29453
 Kingella_kingae_ATCC23330
---------------------------------Kingella_denitrificans_ATCC33394
--------------------- Kingella_oralis_ATCC51147
Eikenella_corrodens_ATCC23834 
-  Neisseria_shayeganii_DSM22246
1 0 0 I Neisseria_sp._oral_taxon_020_str._F0370
'-------------------Neisseria_bacilliformis_ATCCBAA-1200
45T —  Bordetella_pertussis_ATCC9797D
------------------------------- LaribacterJiongkongensis_HLHK9
Chromobacterium_violaceum_ ATCC12472
Pseudogulbenkiania_sp._NH8B
0 .0 3
Figure 3.3: Neighbor-joining tree based on 406 bp of the cpn60 gene. Bootstrap values are 
shown at nodes and are based on 2000 replicates. Point Lonely, Alaska, Neisseria isolates 
are shown in red and are denoted by both GenBank accession number (begins with KJ) and 
our sample number (begins with KH). Additional sequences from the family Neisseriales 
were obtained from the cpn60 database (http://www.cpndb.ca/cpnDB/home.php)
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Figure 3.4: Neighbor-joining tree based on full (1243 bp) 16S ribosomal RNA gene 
sequences. Bootstrap values are shown at nodes and are based on 2000 replicates. Point 
Lonely, Alaska, Neisseria isolates are shown in red and are denoted by both GenBank 
accession number (begins with KF) and our sample number (begins with KH). Additional 
sequences from the family Neisseriales were obtained from the ribosomal database project 
(http://rdp.cme.msu.edu/).
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Figure 3.5: Kaplan-Meier survival curves for embryonated chicken eggs infected with two 
different strains of our Neisseria--like bacterium. Percent survival is shown on the Y-axis, 
days post-infection on the X-axis. Five eggs were inoculated with each dilution (106-102 
bacteria per eggJ of each strain of Neisseria.
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Chapter 4
Use of cellulose filter paper to quantify whole blood mercury in two marine 
mammals: Validation study1 
Abstract
Whole blood is commonly used to assess mercury (Hg) exposure in mammals, but handling 
and shipping samples collected in remote areas can be difficult. We describe and validate 
use of cellulose filter papers (FP) for quantifying whole blood total Hg concentration. 
Advantec Nobuto® FP were soaked with bottlenose dolphin (Tursiops truncatus) or harbor 
seal (Phoca vitulina) whole blood (collected between March and July 2012) then air-dried. 
Untreated blood-soaked FP were analyzed or were eluted with phosphate buffered saline 
(PBS) and the eluate and PBS treated FP Hg concentrations were determined. Total Hg 
from dried blood-soaked FP, post-elution FP, and PBS-based eluate were compared to total 
Hg concentrations from whole blood. Recovery (on a concentration basis) for soaked FP 
relative to whole blood was 0.89±0.15, for post-elution FP was 0.86+0.13, and for eluate 
(with a correction factor applied) was 0.96+0.23. Least squares linear regressions were fit 
for soaked papers (y=1.15x, R2=0.97), post-elution filter papers (y=1.22x, R2=0.95), and for 
eluate with a correction factor applied (y=0.91x+0.03, R2=0.97) as compared to whole 
blood. These data show that FP technology can have a valuable role in monitoring blood Hg 
concentrations in wildlife populations and FPs have the advantage of being easy to use, 
store, and transport as compared to whole blood.
1 Hansen CM, Hueffer K, Gulland F, Wells Randall S, Balmer BC, Castellini J, O'Hara T. 2014.
Use of cellulose filter paper to quantify whole blood mercury in two marine mammals: 
Validation study. J  Wildl Dis 50(2):271-278.
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4.1 Introduction
Mercury (Hg) is a nonessential element that occurs naturally in the environment. 
Mercury is released into the atmosphere via events such as volcanic eruptions and forest 
fires. Since the industrial revolution, anthropogenic releases of Hg into the environment 
have increased, mostly through the burning of fossil fuels and via the mining industry, and 
may occur at concentrations of concern to health in some biota (e.g. Dietz et al., 2009, 
2013). Following deposition of atmospheric Hg into marine and freshwater systems, 
microbial activity (largely sulfate reducing bacteria) can transform Hg to the highly 
bioavailable and toxic monomethylmercury (MeHg+) (Fitzgerald et al., 2007; Parks et al., 
2013). Monomethylmercury can bioaccumulate and biomagnify with trophic levels 
(Coelho et al., 2013), reaching particularly high levels in numerous fish species and 
piscivores (Castoldi et al., 2001; Lemes et al., 2011; Castellini et al., 2012).
Following ingestion, MeHg+ is absorbed via intestinal epithelium passively and via 
active uptake (Leaner and Mason, 2002), and is nearly completely absorbed. Crossing the 
intestinal epithelium, MeHg+ enters the blood where 99% binds to thiol groups, the 
remaining 1% is transported to organs via binding to diffusible low molecular weight thiols 
(Rooney, 2007). Hence blood is the route of exposure (and distribution) for most target 
organs (i.e. the central nervous system) and is a reliable indicator of recent MeHg+ 
exposure (Risher and Amler, 2005).
A key target organ for MeHg+ toxicity is the central nervous system as MeHg+ 
crosses the blood brain barrier via an amino acid transporter and accumulates in nervous 
tissue (Kerper et al., 1992; Caito et al., 2013). Clinical signs of acute toxicity include
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proprioceptive deficits, abnormal postures, blindness, anorexia, coma, and death (Ekino et 
al., 2007). High levels of MeHg+ have been shown to impair components of the nervous 
system (Basu et al., 2006, 2007b). There is concern that, particularly in fish-eating wildlife, 
chronic exposure to MeHg+ can result in poor reproductive success (Basu et al., 2007a). 
There is also concern that Hg levels in wildlife, and in humans that subsist on wildlife 
(particularly in higher latitudes) may be reaching concentrations that can have impacts on 
behavior and health (Grandjean et al., 1997; Castoldi et al., 2001; Oken et al., 2005; Holmes 
et al., 2008; Basu et al., 2009; Bocharova et al., 2013); especially for the fetus and neonate 
(Castellini et al., 2012; Rea et al., 2013).
Whole blood is commonly used to assess Hg exposure (Brookens et al., 2007; Knott 
et al., 2011). Blood is relatively easy to access (relative to target tissues such as the kidney 
and nervous system), is commonly collected by biologists, veterinarians, and others who 
work with wildlife in the field, and is a good tissue for determining Hg status in wild animal 
populations. Hair is easily accessible and used for monitoring Hg status in wildlife and is 
more useful for long-term (chronic) mercury assessment as hair Hg concentration 
represents the average concentration of Hg in circulating blood (Budtz-Jorgensen et al., 
2004).
There are long-term mercury monitoring programs in place for wildlife, particularly 
fish (Great Lakes Fish Monitoring and Surveillance Program,
http://www.epa.gov/grtlakes/monitoring/fish/index.html), and monitoring sometimes 
follows contamination events (Alvarez et al., 2013). Monitoring programs for humans exist 
as well (Alaska Hair Mercury Biomonitoring Program, State of Alaska Epidemiology Bulletin 
2013; Alaska Native Maternal Organics Study (MOM Study) operated by the Alaska Native
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Tribal Health Consortium (ANTHC). However, blood is less commonly used for 
biomonitoring due to relative difficulty (compared to hair) with collection, storage, and 
transport. Collection in the field can be particularly problematic, especially in remote 
locations with limited processing and preservation capabilities. The development of a 
blood sampling regime that can be easily used in the field by scientists, hunters, fishermen, 
or other trained people would facilitate clinical, research, and biomonitoring efforts. Here 
we describe the use of cellulose filter papers for collection of blood in the field and 
subsequent analysis of total Hg concentration in various filter paper matrices in 
comparison with whole blood collected in standard blood collection tubes.
4.2 Materials and Methods
4.2.1 Filter Paper and Samples
Advantec Nobuto® cellulose filter papers (Dublin, CA, USA) were purchased from 
Cole-Parmer (Vernon Hills, IL, USA) and were used for all investigations (fig 4.1). FP were 
either used singly or were fashioned into combs of 5 or 6 papers for use in the field (Curry 
et al., 2011). Whole blood (WB) samples were collected between March and July 2012 from 
wild harbor seals (Phoca vitulina) brought to The Marine Mammal Center (Sausalito, CA, 
USA, MMPA permit no. 932-1905/MA-009526) for rehabilitation and from long-term 
resident bottlenose dolphins (Tursiops truncatus) live captured, sampled, and released 
following health assessments in Sarasota Bay, FL, during May and July 2012, by staff from 
the Chicago Zoological Society (Wells et al. 2004; NMFS Scientific Research Permit No.
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15543, IACUC ll-09-R W l). Blood samples were collected into BD (Becton, Dickinson and 
Company, Franklin Lakes, NJ, USA) Vacutainers™ containing K2EDTA as an anticoagulant. 
The narrow absorbing ends of l0  -  l2  filter papers were soaked in whole blood 
(approximately l0 0  pL/strip) following collection and FP were air dried overnight. The 
fluid sample of whole blood was stored frozen (-20° C). For each individual animal, dried 
filter paper samples were shipped overnight at room temperature in a sealed plastic bag 
with paper towels layered between each sample and blood samples were shipped 
accompanied by freezer packs, to the Wildlife Toxicology Laboratory (WTL) at the 
University of Alaska Fairbanks (Fairbanks, AK, USA).
4.2.2 Sample Preparation
Prior to chemical analysis, control (n = l0 , no blood) and blood-soaked FP were 
freeze-dried for 48 hours in a Labconco FreeZone 6 Plus freeze dryer (Kansas City, MO, 
USA). The narrow absorbing ends of FPc  (control) and FPw b  (soaked, whole blood) were 
cut (using a disposable razor blade) at the junction of the narrow and wide ends (Fig. 4 .l) 
and weighed to determine the dry mass of blood on each paper (Mass WB = Mass FPw b  -  
Average Mass FPc ). All 60 FPc  and three FPw b  from each individual animal sample set were 
analyzed directly for total mercury concentration ([THg]). The [THg] was calculated based 
on the mass of mercury (ng) and mass of blood (~l00m g) on each strip. Three more FPw b  
from each individual animal sample set were separately eluted according to the protocol 
developed by Curry et al. (2 0 l l ) .  Each FPw b  was cut into 5-7 pieces into a 2 mL pre­
weighed cryogenic tube (Thermo Scientific, Waltham, MA, USA) using stainless steel iris
lll
scissors. Each strip was then covered with 400 of phosphate buffered saline (PBS; Gibco, 
Carlsbad, CA, USA) with 1% penicillin-streptomycin (Gibco, Carlsbad, CA, USA). Each 
cryogenic tube was agitated to ensure filter papers were soaked, and were eluted overnight 
(16 hours) at 4o C.
After 16 hours, approximately 200 ^L of eluate (E) were removed from each 
cryovial using a micropipettor. Eluate was transferred to a 1.5 mL microcentrifuge tube 
(Fisher Scientific, Waltham, MA, USA) and held at -50°C until analysis. Post-elution filter 
papers (including ~ 200 l^ of remaining eluting buffer) were again freeze dried for 48 
hours. Following drying, each cryovial (containing post-elution FP pieces) was weighed to 
determine the final weight of the post-elution paper (FPe ).
4.2.3 Mercury Analysis
All samples (WB, FPC, FPWB, FPE, and E ) were analyzed for [THg] on a Milestone 
DMA-80 Direct Mercury Analyzer (Milestone Inc., Shelton, CT, USA) (US EPA method 7473) 
using a 16 point calibration curve from 0.25 ng to 400 ng similar to Knott et al. (2011). 
Samples were analyzed in triplicate when possible (i.e. when there were enough filter 
papers for each sample). Single filter papers (for FPe  a single filter paper included 5-7 cut 
pieces) were analyzed in nickel sample boats and whole blood (~100 [il) and eluates (100 
[il) were analyzed in quartz sample boats. The detection limit using this method was 5 ng/g 
for 100 [il of blood or eluate and 2.5 ng/g for 200p.l of eluate.
Quality control included a 10 ng (1 ng/g) liquid calibration standard (Perkin Elmer, 
Waltham, MA, USA, item #, N9300133), and DORM-3 (National Research Council Canada,
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Ottawa, ON, Canada) and DOLT-4 (National Research Council Canada, Ottawa, ON, Canada) 
certified standards analyzed in triplicate in each DMA80 run. Recoveries were 94.6+0.05% 
ng/g (10 ng), 102.2+4.4% (DORM-3, reference range 0.382+0.060 mg/kg), and 100.1+6.8% 
(DOLT-4, reference range 2.58+0.22 mg/kg).
4.2.4 Calculations and Statistics
Data were managed in Microsoft Excel, and statistics were performed using the 
program R (http://www.r-project.org/. version 2.14.12, downloaded 2/29/2012). Least 
squares linear regressions were fit to FPw b , FPe , and E compared to WB. Confidence 
intervals (95%) for slopes were constructed, and slopes were compared to a test value of 1 
using R package smatr (http://cran.r-project/web/packages/smatr/index.html). Student’s 
paired t-tests were used to compare [THg] means of FPw b , FPe  , and E to WB.
Whole blood data were converted to a dry weight basis using the proportion of dry 
matter in WB. For some calculations and statistics wet weight concentrations are reported, 
for others, dry weight concentrations. To determine the dry weight of blood from each 
species 100 pL of whole blood from each animal was weighed, freeze dried for 48 hours, 
and re-weighed. The dry blood weights were 24.9% + 1.8 SD for harbor seals and 20.5 + 
0.7% for bottlenose dolphins.
A correction factor was applied to eluate samples to estimate the original WB (wet) 
[THg] (Fig. 4.2). The elution process involves adding 400 pL of PBS (~0.400 g) to strips 
(FPw b ) containing dried components (0.2 -  0.25 g) from approximately 100 pL (~0.100 g) 
of blood. Therefore a correction factor (CF) was estimated for each sample as follows:
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CF = Mass of E/Mass of WBwet
= (0.400 g+Weight (in g) of dry blood on FPw b )/0.100 g.
This correction factor was then applied to eluate [THg]:
Ec f  = E*CF k WB (wet)
This correction factor result was compared to the original WB (wet) [THg].
4.3 Results
The average weight of the narrow part (Fig. 4.1) of FPc  is 0.0466 + 0.002 g (n = 10). 
Single control filter papers not soaked with blood were below the detection limit of the 
DMA-80 (0.5 ng/FP, n = 10). Mean [THg] values (on a concentration basis) for WB, FPw b , 
FPe , and E are summarized in Table 4.1. FPw b , FPe , and E [THg] relative to [THg] in WB in 
matched samples is summarized in Figure 4.3. For dolphins, the relative proportion of 
[THg] in FPw b  and FPe  compared to whole blood is 0.87+0.08 and 0.82+0.13, respectively. 
For harbor seals, the relative proportion of [THg] in FPw b  and FPe  compared to whole blood 
was more variable at 0.95 ± 0.42 and 0.92+0.32, respectively. The mean difference 
between the proportion of [THg] FPw b  compared to WB is 0.04 (p<0.001), between FPe  and 
WB is 0.05 (p<0.001), and there is no mean significant difference between Ed WB (p=0.4) 
(paired t-tests).
Figure 4.4 shows [THg] WB regressed on FPw b , FPe  , and E values. Data for WB, FPw b , 
FPe , and E are presented on a wet weight basis. The R2 for blood-soaked filter papers is 
0.97, for post-elution filter papers is 0.95, and for eluate (with correction factor applied) is
0.97. A 95%  confidence interval for the slope is 1.12 -  1.19 for WB regressed on FPw b ,
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1.18-1.32 for WB regressed on FPe , and 0.89-0.97 for WB regressed on E. Tests for each 
slope (Ho: slope =1 or y=x) indicates p <0.01 for each regression (Fig 4.3).
4.4 Discussion
We used blood soaked FP samples to assess mercury concentrations in the blood of 
bottlenose dolphins and harbor seals. The values for whole blood total mercury for 
bottlenose dolphins and harbor seals from our study populations (Table 4.1) are within the 
ranges previously reported (Brookens et al., 2007; Woshner et al., 2008).
Advantec Nobuto filter paper strips are uniform in size and weight (0.0446+0.002 g), 
and their [THg] is below the detection limit of a DMA80 (<0.5 ng). Our data support that 
cellulose FPs soaked in whole blood and air-dried are an accurate and reproducible way to 
quantify whole blood [THg] for some mammals. Overall recoveries on a concentration 
basis are very high, ranging from 82-95%, when compared to whole blood concentration 
for FPw b , FPe , and Ec f  (Fig 4.3). Additionally, with R2 values of 0.97, 0.95, and 0.97 
respectively for FPw b , FPe , and Ec f  (Fig 4.4), whole blood mercury concentration can be 
easily estimated from dried and/or eluted samples, provided [THg] is high enough to be 
detected.
This technique promises to be valuable to scientists, wildlife managers, 
veterinarians, and others needing a simple, inexpensive, and highly effective method for 
collecting blood samples for mercury analysis in combination with other assays. Perhaps 
even more importantly, these filter papers could be distributed to hunters and used in the 
field to increase the scope of wildlife monitoring programs. Programs aimed at developing 
community-based wildlife health monitoring programs exist (Brook et al., 2009; Alaska
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Native Harbor Seal Commission Biosampling Program, Alaska Native Tribal Health 
Consortium, Division of Community Health, Community Environment and Safety 
Department; http://harborsealcommission.org/biosample.htm), and distribution of filter 
paper sample kits (including instructions and pre-paid shipping labels) through outlets like 
these would benefit mercury and other disease/health monitoring efforts around the globe 
(Curry, et al., 2011).
Our findings demonstrate that mercury in blood elutes readily, and our methods 
allow half of the eluate and roughly half of the mercury to remain with the post-elution 
filter paper (FPe ) (Fig. 4.4). We also show that Hg-associated dry components of blood 
likely distribute in a similar way by using a correction factor that demonstrated results 
with a strong correlation to WB [THg]. Since mercury is bound to sulfhydryl groups on 
hemoglobin molecules (Weed et al., 1962), we hypothesize that the hemoglobin is following 
this same pattern and is moving into the eluate, and half of that remains on the FPe  with the 
residual 200 [iL of buffer. Based on this we have developed a conceptual model of the 
elution process describing the utility of predicting WB [THg] directly using blood soaked 
FPw b  and indirect methods that use certain post elution products (FPe , E) (Fig. 4.4).
While blood is not as easy to collect as hair, filter paper technology facilitates blood 
collection and makes it easier to store and ship air-dried blood. Hair provides a long-term 
picture of mercury status (Budtz-Jorgensen et al., 2004), while blood represents short-term 
exposure, and is the route of exposure for target organs (the central nervous system and 
kidneys). The combination of dried filter papers and hair samples, both of which can be 
stored at room temperature and shipped under ambient conditions will allow wildlife 
scientists to obtain a more complete picture of the mercury status in populations of interest.
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The designed use of these filter papers is for protein (antibody) preservation for 
antibody detection (serology). We have shown the added advantage of being able to use 
either FPw b , FPe , or E for quantifying mercury in whole blood. Previous studies have used 
filter paper eluate to validate serologic use in wildlife populations (Curry et al., 2011). We 
emphasize the excellent correlations between [THg] in WB and both FPe  and E (Fig. 4.4). 
Thus one can utilize the filter paper eluate (E) as intended for serology, and use any 
remaining FPw b  or FPe  to quantify mercury. This type of use could be a significant 
advantage if the available blood volume is limited, either in small species, or in situations 
where hunters or wildlife professionals are unwilling or unable to obtain large quantities of 
blood.
One unknown factor at this point pertains to the shelf life of these samples. All of 
our analyses were conducted within 8 months of collecting samples on filter papers. It 
would be important to see if similar results would be obtained with long-term storage. 
However, we do not anticipate volatilization or degradation to be significant for [THg] 
measures as compared to more vulnerable components such as antibodies.
In summary, Advantec Nobuto cellulose filter papers, by virtue of low background 
mercury (below detection), no signal interference, and uniform design, allow for reliable 
quantification of [THg] in whole blood. They are easy to transport, easy to use, and do not 
have to be refrigerated or frozen following sample collection and air-drying. Additionally, 
the filter papers may lend themselves to dual-purpose diagnostics via serology and [THg] 
quantification, which may be especially important in small species and under field 
conditions.
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4.5 Conclusion
This filter paper technique promises to be broadly applicable wherever field 
sampling of whole blood for [THg] is needed. The strips can be air dried, do not need to be 
refrigerated, and theoretically have a long, stable shelf life once samples are collected. This 
method will be particularly useful in monitoring [THg] in subsistence foods in remote 
Alaskan communities, where Alaska Native peoples often subsist on fish eating marine 
mammals. Application of this technology to human fish consumer blood sampling, in 
conjunction with hair monitoring programs, should also be considered.
4.6 Acknowledgments
The authors thank The Marine Mammal Center and the Chicago Zoological Society’s 
Sarasota Dolphin Research Program staff and volunteers for collecting whole blood and FP 
samples. Dolphin blood samples were collected during health assessments funded by 
Dolphin Quest and the Office of Naval Research. We thank Jennifer Yordy and Kristina 
Cammen for blood processing assistance during the dolphin health assessments, and John 
Harley, Meghan Templeton and Gary Lose for assistance in the laboratory. Analytical work 
was funded by the Rural Alaska Monitoring Program (RAMP) funded via the Alaska Native 
Tribal Health Consortium (ANTHC) from a grant from the US Fish and Wildlife Service, 
Arctic Landscape Conservation Consortium.
118
Table 4.1: Mean, range, standard deviation (S.D.), and sample number (n) for total mercury concentration [THg] in bottlenose 
dolphin (T. truncatus, n=25) and harbor seal (P. vitulina, n=34) whole blood (WB), filter paper (FPw b , FPe ), and eluate (E) 
samples.
Species WB
^g/g
FPw b
^ g
FPe
^ g
E
^ g
Wet* Dry** Wet** Dry* Wet** Dry* Wet* CF Applied**
Bottlenose Dolphin
Mean 0.48 2.39 0.41 2.06 0.39 1.97 0.12 0.50
S.D. 0.33 1.66 0.28 1.42 0.27 1.42 0.08 0.35
Range 0.12-1.34 0.61-6.71 0.09-1.15 0.47-5.75 0.09-0.97 0.45-5.67 0.03-0.35 0.13-1.51
Harbor Seal
Mean 0.16 0.64 0.14 0.56 0.13 0.55 0.03 0.13
S.D. 0.11 0.42 0.10 0.38 0.09 0.36 0.02 0.09
Range 0.03-0.45 0.12-1.78 0.03-0.42 0.12-1.67 0.04-0.41 0.14-1.66 0.01-0.11 0.03-0.46
*Measured, **Calculated
FPw b : FP soaked in whole blood, FPe : Post-elution FP, E: Eluate 
CF: Correction Factor
C u t h e re
Figure 4.1: Single filter paper (FP) with placement of post blood soaking cut for processing 
marked with black line.
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Original volume 
100 nL W B (75% H20) 
50 ng Hg
FPwb 
50 ng Hg
FPe = FPc + 200 uL PBS 
+ 12.5 mg dry blood 
components
25 ng I
E = 200 uL PBS 
+ 12.5 mg dry blood 
components 
Correction Factor 4.2
25 ng Hg
Figure 4.2: A conceptual model of the elution process. Each filter paper is soaked in 
approximately 100 ^L of whole blood (original volume). After drying, approximately 20-25 mg 
(half) of dry blood products remain on filter paper (FPWB). These FPWB can be analyzed for 
[THg] directly, or eluted as follows. The dry blood products on FPWB are eluted in 400 ^L of 
PBS, 200 ^L is collected as eluate (the remaining 200 ^L remains soaked into FPE). FPE or E 
can then be analyzed for [THg].
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1.4
Overall H arbor Seal Dolphin
Figure 4.3: Proportion of [THg] (^g/g) in FPW b , FPe , and E relative to whole blood (WB = 1) for 
bottlenose dolphin (n=25) and harbor seal (n=34) samples. Error bars indicate one standard 
deviation from the mean. *Indicates significant difference in means of paired samples when 
compared to WB as gold standard (p<0.05).
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FPwb t™ g] w et w eight
FPe [THg] ng/g w et w eight
E [THg] ng/g w et w eight
Figure 4.4: Linear regressions of WB on FPWB, FPE, and E (with dilution factor applied). All 
slopes are not equal to one. Dashed lines are a 95% confidence band for the slope. A line of 
unity (y=x) is shown in each panel.
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General Conclusions
The studies included in this thesis were aimed at developing and implementing new 
ways to survey for infectious and noninfectious disease agents in wildlife. Given the 
emergence of the One Health concept, that most infectious diseases in humans are of 
animal origin (1), and that a changing climate will modify the pattern of disease on the 
landscape (2), it is important to have reliable diagnostic methods ready. First, the history 
and epidemiology of tularemia, a zoonotic disease of importance to the state of Alaska (and 
the Northern hemisphere) was reviewed for the state of Alaska (3). Then a broad-based 
16S ribosomal RNA gene PCR and sequencing technique was developed and implemented 
by screening a wide variety of wildlife tissue samples. Next, this broad-based 16S rRNA 
gene PCR technique was used as an initial screening and identification tool in an 
investigation of avian embryo mortality on the Arctic Coastal Plain of Alaska. Finally, a filter 
paper-based method for quantifying whole blood mercury levels was validated and shown 
to be a potentially very useful field sampling technique (4).
I began by reviewing tularemia in Alaska, a zoonotic disease that is present in the 
state of Alaska and throughout the Northern Hemisphere. Epidemiologic work shows that 
most human tularemia patients who reported recent animal exposure stated exposure to 
hare or muskrat, which fits with either or both of them being a suspected reservoir (3). 
Molecular typing of recent Alaskan F. tularensis isolates suggest either multiple 
introductions of F. tularensis to the state, or that F. tularensis has been present in the state 
for a long time and has diversified greatly. Further work is warranted to increase our 
understanding of tularemia in Alaska and will help guide future public health surveillance 
and intervention.
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Accurate and broad-based methods are needed to identify bacterial pathogens (such 
as Francisella tularensis) in animal tissue samples. The next chapter of this thesis described 
the development of a PCR method and a qPCR method for identifying bacterial DNA in 
tissues. The methods that we developed work particularly well in animals where infectious 
disease is suspected (i.e. necropsy specimens), vs. as a screening tool for large populations. 
In many cases interpretable DNA sequences are obtained without the need for cloning.
The major advantages to the PCR techniques described here is that they are 
extremely broad-based (i.e. not agent specific). Additionally, these methods are cost 
effective, quick, and the qPCR protocol leaves potential for high-throughput. Limitations to 
these techniques include that it can only be used on tissues from sterile areas of the body. 
Also, either of the PCR methods developed here will amplify pathogen DNA, but will also 
amplify DNA from non-pathogenic and contaminant organisms, so care must be taken 
when interpreting sequence results. Despite these limitations, these broad-based PCR 
methods have a place in the identification of bacterial disease in wildlife.
Following the development of broad-based PCR surveillance methods for bacterial 
DNA, we were able to use these methods to investigate causes of embryo mortality in 
greater white-fronted geese (Anser albifrons) in Arctic Alaska. We identified 11 species of 
bacteria in the contents of nonviable (addled) white-fronted goose eggs, and showed that 
the 4 most commonly isolated bacteria are capable of causing embryo mortality by 
performing an infection study.
Surprisingly, we identified a bacterium in the genus Neisseria in the majority of our 
addled eggs. We are unaware of any reports of species in this genus being isolated from 
bird eggs. Based on DNA sequence data, our Neisseria isolate is most closely related to N.
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canis or N. animaloris, but none share more than 97%  16S rRNA gene sequence identity. 
Additional sequencing of the cpn60 gene hints that this is a unique bacterium in the genus. 
We do not know the source or route of infection, and swab data reveal that Neisseria DNA is 
present in nest material, on eggshells, and in the cloacae of female geese. Future work 
should focus on identifying the source and route of transmission of these bacteria.
Following this investigation of avian embryo mortality, we focused our efforts on 
developing a filter paper-based method for monitoring mercury exposure in whole blood in 
wild animals. These data show that filter paper samples are an accurate and reproducible 
way to quantify whole blood total mercury [THg] for some animals (4).
Overall recoveries on a concentration basis were excellent, and our R# values show 
that whole blood [THg] can be estimated from dried or eluted filter paper samples. The 
findings from this chapter show that the mercury in blood elutes readily from the filter 
papers. We showed that roughly half of the eluate remains with the post-elution filter 
paper, and that Hg-associated dry components of blood likely distribute in a similar way. 
From this, we developed a conceptual model of the elution process that shows where the 
mercury in an initial whole blood sample ends up whether you analyze a whole air-dried 
FP or elute and analyze [THg] on an eluted sample or post-elution FP.
This thesis as a whole has investigated the use of two novel methods for 
surveillance of infectious and noninfectious disease in wildlife. We also used one of these 
techniques in the first investigation into avian embryo mortality in waterfowl and in the 
Arctic. These methods promise to be valuable tools for wildlife professionals and will 
benefit human, wildlife, and ecosystem health.
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